id	sid	tid	token	lemma	pos
ajlm-622	1	1	abstract	abstract	ADJ
ajlm-622	1	2	introduction	introduction	NOUN
ajlm-622	1	3	methods	method	NOUN
ajlm-622	1	4	results	result	VERB
ajlm-622	1	5	discussion	discussion	NOUN
ajlm-622	1	6	acknowledgements	acknowledgement	NOUN
ajlm-622	1	7	references	reference	NOUN
ajlm-622	1	8	about	about	ADP
ajlm-622	1	9	the	the	DET
ajlm-622	1	10	author(s	author(s	NOUN
ajlm-622	1	11	)	)	PUNCT
ajlm-622	1	12	terver	terver	PROPN
ajlm-622	1	13	m.	m.	NOUN
ajlm-622	1	14	akindigh	akindigh	PROPN
ajlm-622	1	15	infectious	infectious	ADJ
ajlm-622	1	16	diseases	disease	NOUN
ajlm-622	1	17	unit	unit	NOUN
ajlm-622	1	18	,	,	PUNCT
ajlm-622	1	19	jos	jos	PROPN
ajlm-622	1	20	university	university	PROPN
ajlm-622	1	21	teaching	teaching	NOUN
ajlm-622	1	22	hospital	hospital	NOUN
ajlm-622	1	23	,	,	PUNCT
ajlm-622	1	24	jos	jos	PROPN
ajlm-622	1	25	,	,	PUNCT
ajlm-622	1	26	nigeria	nigeria	PROPN
ajlm-622	1	27	abba	abba	PROPN
ajlm-622	1	28	o.	o.	PROPN
ajlm-622	1	29	joseph	joseph	PROPN
ajlm-622	1	30	infectious	infectious	ADJ
ajlm-622	1	31	diseases	disease	NOUN
ajlm-622	1	32	unit	unit	NOUN
ajlm-622	1	33	,	,	PUNCT
ajlm-622	1	34	jos	jos	PROPN
ajlm-622	1	35	university	university	PROPN
ajlm-622	1	36	teaching	teaching	NOUN
ajlm-622	1	37	hospital	hospital	NOUN
ajlm-622	1	38	,	,	PUNCT
ajlm-622	1	39	jos	jos	PROPN
ajlm-622	1	40	,	,	PUNCT
ajlm-622	1	41	nigeria	nigeria	PROPN
ajlm-622	1	42	christiana	christiana	PROPN
ajlm-622	1	43	o.	o.	PROPN
ajlm-622	1	44	robert	robert	PROPN
ajlm-622	1	45	department	department	PROPN
ajlm-622	1	46	of	of	ADP
ajlm-622	1	47	microbiology	microbiology	NOUN
ajlm-622	1	48	,	,	PUNCT
ajlm-622	1	49	faculty	faculty	NOUN
ajlm-622	1	50	of	of	ADP
ajlm-622	1	51	natural	natural	ADJ
ajlm-622	1	52	sciences	science	NOUN
ajlm-622	1	53	,	,	PUNCT
ajlm-622	1	54	university	university	NOUN
ajlm-622	1	55	of	of	ADP
ajlm-622	1	56	jos	jos	PROPN
ajlm-622	1	57	,	,	PUNCT
ajlm-622	1	58	jos	jos	PROPN
ajlm-622	1	59	,	,	PUNCT
ajlm-622	1	60	nigeria	nigeria	PROPN
ajlm-622	1	61	ocheme	ocheme	PROPN
ajlm-622	1	62	j.	j.	PROPN
ajlm-622	1	63	okojokwu	okojokwu	PROPN
ajlm-622	1	64	department	department	PROPN
ajlm-622	1	65	of	of	ADP
ajlm-622	1	66	microbiology	microbiology	NOUN
ajlm-622	1	67	,	,	PUNCT
ajlm-622	1	68	faculty	faculty	NOUN
ajlm-622	1	69	of	of	ADP
ajlm-622	1	70	natural	natural	ADJ
ajlm-622	1	71	sciences	science	NOUN
ajlm-622	1	72	,	,	PUNCT
ajlm-622	1	73	university	university	NOUN
ajlm-622	1	74	of	of	ADP
ajlm-622	1	75	jos	jos	PROPN
ajlm-622	1	76	,	,	PUNCT
ajlm-622	1	77	jos	jos	PROPN
ajlm-622	1	78	,	,	PUNCT
ajlm-622	1	79	nigeria	nigeria	PROPN
ajlm-622	1	80	juliet	juliet	PROPN
ajlm-622	1	81	n.	n.	PROPN
ajlm-622	1	82	okechalu	okechalu	PROPN
ajlm-622	1	83	department	department	PROPN
ajlm-622	1	84	of	of	ADP
ajlm-622	1	85	microbiology	microbiology	NOUN
ajlm-622	1	86	,	,	PUNCT
ajlm-622	1	87	faculty	faculty	NOUN
ajlm-622	1	88	of	of	ADP
ajlm-622	1	89	natural	natural	ADJ
ajlm-622	1	90	sciences	science	NOUN
ajlm-622	1	91	,	,	PUNCT
ajlm-622	1	92	university	university	NOUN
ajlm-622	1	93	of	of	ADP
ajlm-622	1	94	jos	jos	PROPN
ajlm-622	1	95	,	,	PUNCT
ajlm-622	1	96	jos	jos	PROPN
ajlm-622	1	97	,	,	PUNCT
ajlm-622	1	98	nigeria	nigeria	PROPN
ajlm-622	1	99	joseph	joseph	PROPN
ajlm-622	1	100	a.	a.	PROPN
ajlm-622	1	101	anejo	anejo	PROPN
ajlm-622	1	102	-	-	PUNCT
ajlm-622	1	103	okopi	okopi	PROPN
ajlm-622	1	104	department	department	PROPN
ajlm-622	1	105	of	of	ADP
ajlm-622	1	106	microbiology	microbiology	NOUN
ajlm-622	1	107	,	,	PUNCT
ajlm-622	1	108	faculty	faculty	NOUN
ajlm-622	1	109	of	of	ADP
ajlm-622	1	110	natural	natural	ADJ
ajlm-622	1	111	sciences	science	NOUN
ajlm-622	1	112	,	,	PUNCT
ajlm-622	1	113	university	university	NOUN
ajlm-622	1	114	of	of	ADP
ajlm-622	1	115	jos	jos	PROPN
ajlm-622	1	116	,	,	PUNCT
ajlm-622	1	117	jos	jos	PROPN
ajlm-622	1	118	,	,	PUNCT
ajlm-622	1	119	nigeria	nigeria	PROPN
ajlm-622	1	120	citation	citation	PROPN
ajlm-622	1	121	akindigh	akindigh	PROPN
ajlm-622	1	122	tm	tm	PROPN
ajlm-622	1	123	,	,	PUNCT
ajlm-622	1	124	joseph	joseph	PROPN
ajlm-622	1	125	ao	ao	PROPN
ajlm-622	1	126	,	,	PUNCT
ajlm-622	1	127	robert	robert	PROPN
ajlm-622	1	128	co	co	PROPN
ajlm-622	1	129	,	,	PUNCT
ajlm-622	1	130	okojokwu	okojokwu	PROPN
ajlm-622	1	131	oj	oj	PROPN
ajlm-622	1	132	,	,	PUNCT
ajlm-622	1	133	okechalu	okechalu	PROPN
ajlm-622	1	134	jn	jn	PROPN
ajlm-622	1	135	,	,	PUNCT
ajlm-622	1	136	anejo	anejo	PROPN
ajlm-622	1	137	-	-	PUNCT
ajlm-622	1	138	okopi	okopi	NOUN
ajlm-622	1	139	ja	ja	PROPN
ajlm-622	1	140	.	.	PUNCT
ajlm-622	2	1	seroprevalence	seroprevalence	NOUN
ajlm-622	2	2	of	of	ADP
ajlm-622	2	3	hepatitis	hepatitis	PROPN
ajlm-622	2	4	b	b	PROPN
ajlm-622	2	5	virus	virus	PROPN
ajlm-622	2	6	co	co	NOUN
ajlm-622	2	7	-	-	NOUN
ajlm-622	2	8	infection	infection	NOUN
ajlm-622	2	9	among	among	ADP
ajlm-622	2	10	hiv-1	hiv-1	ADJ
ajlm-622	2	11	-	-	ADJ
ajlm-622	2	12	positive	positive	ADJ
ajlm-622	2	13	patients	patient	NOUN
ajlm-622	2	14	in	in	ADP
ajlm-622	2	15	north	north	NOUN
ajlm-622	2	16	-	-	PUNCT
ajlm-622	2	17	central	central	NOUN
ajlm-622	2	18	nigeria	nigeria	PROPN
ajlm-622	2	19	:	:	PUNCT
ajlm-622	2	20	the	the	DET
ajlm-622	2	21	urgent	urgent	ADJ
ajlm-622	2	22	need	need	NOUN
ajlm-622	2	23	for	for	ADP
ajlm-622	2	24	surveillance	surveillance	NOUN
ajlm-622	2	25	.	.	PUNCT
ajlm-622	3	1	afr	afr	PROPN
ajlm-622	3	2	j	j	PROPN
ajlm-622	3	3	lab	lab	PROPN
ajlm-622	3	4	med	med	PROPN
ajlm-622	3	5	.	.	PUNCT
ajlm-622	3	6	2019;8(1	2019;8(1	NOUN
ajlm-622	3	7	)	)	PUNCT
ajlm-622	3	8	,	,	PUNCT
ajlm-622	4	1	a622	a622	PROPN
ajlm-622	4	2	.	.	PROPN
ajlm-622	5	1	https://doi.org/10.4102/ajlm.v8i1.622	https://doi.org/10.4102/ajlm.v8i1.622	AUX
ajlm-622	5	2	brief	brief	PROPN
ajlm-622	5	3	report	report	NOUN
ajlm-622	5	4	seroprevalence	seroprevalence	NOUN
ajlm-622	5	5	of	of	ADP
ajlm-622	5	6	hepatitis	hepatitis	PROPN
ajlm-622	5	7	b	b	PROPN
ajlm-622	5	8	virus	virus	PROPN
ajlm-622	5	9	co	co	NOUN
ajlm-622	5	10	-	-	NOUN
ajlm-622	5	11	infection	infection	NOUN
ajlm-622	5	12	among	among	ADP
ajlm-622	5	13	hiv-1	hiv-1	ADJ
ajlm-622	5	14	-	-	ADJ
ajlm-622	5	15	positive	positive	ADJ
ajlm-622	5	16	patients	patient	NOUN
ajlm-622	5	17	in	in	ADP
ajlm-622	5	18	north	north	NOUN
ajlm-622	5	19	-	-	PUNCT
ajlm-622	5	20	central	central	NOUN
ajlm-622	5	21	nigeria	nigeria	PROPN
ajlm-622	5	22	:	:	PUNCT
ajlm-622	5	23	the	the	DET
ajlm-622	5	24	urgent	urgent	ADJ
ajlm-622	5	25	need	need	NOUN
ajlm-622	5	26	for	for	ADP
ajlm-622	5	27	surveillance	surveillance	NOUN
ajlm-622	5	28	terver	terver	PROPN
ajlm-622	5	29	m.	m.	PROPN
ajlm-622	5	30	akindigh	akindigh	PROPN
ajlm-622	5	31	,	,	PUNCT
ajlm-622	5	32	abba	abba	PROPN
ajlm-622	5	33	o.	o.	PROPN
ajlm-622	5	34	joseph	joseph	PROPN
ajlm-622	5	35	,	,	PUNCT
ajlm-622	5	36	christiana	christiana	PROPN
ajlm-622	5	37	o.	o.	PROPN
ajlm-622	5	38	robert	robert	PROPN
ajlm-622	5	39	,	,	PUNCT
ajlm-622	5	40	ocheme	ocheme	PROPN
ajlm-622	5	41	j.	j.	PROPN
ajlm-622	5	42	okojokwu	okojokwu	PROPN
ajlm-622	5	43	,	,	PUNCT
ajlm-622	5	44	juliet	juliet	PROPN
ajlm-622	5	45	n.	n.	PROPN
ajlm-622	5	46	okechalu	okechalu	PROPN
ajlm-622	5	47	,	,	PUNCT
ajlm-622	5	48	joseph	joseph	PROPN
ajlm-622	5	49	a.	a.	PROPN
ajlm-622	5	50	anejo	anejo	PROPN
ajlm-622	5	51	-	-	PUNCT
ajlm-622	5	52	okopi	okopi	NOUN
ajlm-622	5	53	received	receive	VERB
ajlm-622	5	54	:	:	PUNCT
ajlm-622	5	55	09	09	NUM
ajlm-622	5	56	mar	mar	PROPN
ajlm-622	5	57	.	.	PROPN
ajlm-622	5	58	2017	2017	NUM
ajlm-622	5	59	;	;	PUNCT
ajlm-622	5	60	accepted	accept	VERB
ajlm-622	5	61	:	:	PUNCT
ajlm-622	5	62	04	04	NUM
ajlm-622	5	63	dec	dec	PROPN
ajlm-622	5	64	.	.	PROPN
ajlm-622	5	65	2018	2018	NUM
ajlm-622	5	66	;	;	PUNCT
ajlm-622	5	67	published	publish	VERB
ajlm-622	5	68	:	:	PUNCT
ajlm-622	5	69	27	27	NUM
ajlm-622	5	70	june	june	PROPN
ajlm-622	5	71	2019	2019	NUM
ajlm-622	5	72	copyright	copyright	NOUN
ajlm-622	5	73	:	:	PUNCT
ajlm-622	5	74	©	©	PROPN
ajlm-622	5	75	2019	2019	NUM
ajlm-622	5	76	.	.	PUNCT
ajlm-622	6	1	the	the	DET
ajlm-622	6	2	author(s	author(s	PROPN
ajlm-622	6	3	)	)	PUNCT
ajlm-622	6	4	.	.	PUNCT
ajlm-622	7	1	licensee	licensee	NOUN
ajlm-622	7	2	:	:	PUNCT
ajlm-622	7	3	aosis	aosis	NOUN
ajlm-622	7	4	.	.	PUNCT
ajlm-622	8	1	this	this	PRON
ajlm-622	8	2	is	be	AUX
ajlm-622	8	3	an	an	DET
ajlm-622	8	4	open	open	ADJ
ajlm-622	8	5	access	access	NOUN
ajlm-622	8	6	article	article	NOUN
ajlm-622	8	7	distributed	distribute	VERB
ajlm-622	8	8	under	under	ADP
ajlm-622	8	9	the	the	DET
ajlm-622	8	10	terms	term	NOUN
ajlm-622	8	11	of	of	ADP
ajlm-622	8	12	the	the	DET
ajlm-622	8	13	creative	creative	ADJ
ajlm-622	8	14	commons	common	NOUN
ajlm-622	8	15	attribution	attribution	NOUN
ajlm-622	8	16	license	license	NOUN
ajlm-622	8	17	,	,	PUNCT
ajlm-622	8	18	which	which	PRON
ajlm-622	8	19	permits	permit	VERB
ajlm-622	8	20	unrestricted	unrestricted	ADJ
ajlm-622	8	21	use	use	NOUN
ajlm-622	8	22	,	,	PUNCT
ajlm-622	8	23	distribution	distribution	NOUN
ajlm-622	8	24	,	,	PUNCT
ajlm-622	8	25	and	and	CCONJ
ajlm-622	8	26	reproduction	reproduction	NOUN
ajlm-622	8	27	in	in	ADP
ajlm-622	8	28	any	any	DET
ajlm-622	8	29	medium	medium	NOUN
ajlm-622	8	30	,	,	PUNCT
ajlm-622	8	31	provided	provide	VERB
ajlm-622	8	32	the	the	DET
ajlm-622	8	33	original	original	ADJ
ajlm-622	8	34	work	work	NOUN
ajlm-622	8	35	is	be	AUX
ajlm-622	8	36	properly	properly	ADV
ajlm-622	8	37	cited	cite	VERB
ajlm-622	8	38	.	.	PUNCT
ajlm-622	9	1	abstract	abstract	ADV
ajlm-622	9	2	we	we	PRON
ajlm-622	9	3	report	report	VERB
ajlm-622	9	4	the	the	DET
ajlm-622	9	5	seroprevalence	seroprevalence	NOUN
ajlm-622	9	6	of	of	ADP
ajlm-622	9	7	hepatitis	hepatitis	PROPN
ajlm-622	9	8	b	b	PROPN
ajlm-622	9	9	surface	surface	NOUN
ajlm-622	9	10	antigen	antigen	ADV
ajlm-622	9	11	among	among	ADP
ajlm-622	9	12	hiv	hiv	PROPN
ajlm-622	9	13	-	-	PUNCT
ajlm-622	9	14	positive	positive	ADJ
ajlm-622	9	15	patients	patient	NOUN
ajlm-622	9	16	at	at	ADP
ajlm-622	9	17	a	a	DET
ajlm-622	9	18	clinic	clinic	NOUN
ajlm-622	9	19	in	in	ADP
ajlm-622	9	20	north	north	NOUN
ajlm-622	9	21	-	-	PUNCT
ajlm-622	9	22	central	central	NOUN
ajlm-622	9	23	nigeria	nigeria	PROPN
ajlm-622	9	24	.	.	PUNCT
ajlm-622	10	1	screening	screen	VERB
ajlm-622	10	2	for	for	ADP
ajlm-622	10	3	hepatitis	hepatitis	PROPN
ajlm-622	10	4	b	b	PROPN
ajlm-622	10	5	virus	virus	NOUN
ajlm-622	10	6	was	be	AUX
ajlm-622	10	7	based	base	VERB
ajlm-622	10	8	on	on	ADP
ajlm-622	10	9	serological	serological	ADJ
ajlm-622	10	10	markers	marker	NOUN
ajlm-622	10	11	.	.	PUNCT
ajlm-622	11	1	alanine	alanine	PROPN
ajlm-622	11	2	aminotransferase	aminotransferase	PROPN
ajlm-622	11	3	levels	level	NOUN
ajlm-622	11	4	and	and	CCONJ
ajlm-622	11	5	cd4	cd4	PROPN
ajlm-622	11	6	+	+	PROPN
ajlm-622	11	7	t	t	PROPN
ajlm-622	11	8	-	-	PUNCT
ajlm-622	11	9	lymphocyte	lymphocyte	NOUN
ajlm-622	11	10	counts	count	NOUN
ajlm-622	11	11	were	be	AUX
ajlm-622	11	12	compared	compare	VERB
ajlm-622	11	13	between	between	ADP
ajlm-622	11	14	patients	patient	NOUN
ajlm-622	11	15	.	.	PUNCT
ajlm-622	12	1	the	the	DET
ajlm-622	12	2	study	study	NOUN
ajlm-622	12	3	showed	show	VERB
ajlm-622	12	4	that	that	SCONJ
ajlm-622	12	5	9.2	9.2	NUM
ajlm-622	12	6	%	%	NOUN
ajlm-622	12	7	were	be	AUX
ajlm-622	12	8	positive	positive	ADJ
ajlm-622	12	9	for	for	SCONJ
ajlm-622	12	10	hepatitis	hepatitis	PROPN
ajlm-622	12	11	b	b	PROPN
ajlm-622	12	12	surface	surface	NOUN
ajlm-622	12	13	antigen	antigen	ADV
ajlm-622	12	14	with	with	ADP
ajlm-622	12	15	significant	significant	ADJ
ajlm-622	12	16	differences	difference	NOUN
ajlm-622	12	17	between	between	ADP
ajlm-622	12	18	alanine	alanine	NOUN
ajlm-622	12	19	aminotransferase	aminotransferase	PROPN
ajlm-622	12	20	levels	level	NOUN
ajlm-622	12	21	of	of	ADP
ajlm-622	12	22	patients	patient	NOUN
ajlm-622	12	23	with	with	ADP
ajlm-622	12	24	and	and	CCONJ
ajlm-622	12	25	without	without	ADP
ajlm-622	12	26	hepatitis	hepatitis	PROPN
ajlm-622	12	27	b	b	PROPN
ajlm-622	12	28	virus	virus	NOUN
ajlm-622	12	29	.	.	PUNCT
ajlm-622	13	1	we	we	PRON
ajlm-622	13	2	recommend	recommend	VERB
ajlm-622	13	3	a	a	DET
ajlm-622	13	4	national	national	ADJ
ajlm-622	13	5	surveillance	surveillance	NOUN
ajlm-622	13	6	system	system	NOUN
ajlm-622	13	7	to	to	PART
ajlm-622	13	8	monitor	monitor	VERB
ajlm-622	13	9	control	control	NOUN
ajlm-622	13	10	efforts	effort	NOUN
ajlm-622	13	11	.	.	PUNCT
ajlm-622	14	1	keywords	keyword	NOUN
ajlm-622	14	2	:	:	PUNCT
ajlm-622	14	3	antiretroviral	antiretroviral	ADJ
ajlm-622	14	4	therapy	therapy	NOUN
ajlm-622	14	5	;	;	PUNCT
ajlm-622	14	6	alanine	alanine	NOUN
ajlm-622	14	7	aminotransferase	aminotransferase	NOUN
ajlm-622	14	8	;	;	PUNCT
ajlm-622	14	9	cd4	cd4	PROPN
ajlm-622	14	10	+	+	PROPN
ajlm-622	14	11	t	t	PROPN
ajlm-622	14	12	-	-	PUNCT
ajlm-622	14	13	lymphocytes	lymphocyte	NOUN
ajlm-622	14	14	;	;	PUNCT
ajlm-622	14	15	hepatitis	hepatitis	PROPN
ajlm-622	14	16	b	b	PROPN
ajlm-622	14	17	virus	virus	NOUN
ajlm-622	14	18	;	;	PUNCT
ajlm-622	14	19	hiv	hiv	PROPN
ajlm-622	14	20	;	;	PUNCT
ajlm-622	14	21	serological	serological	ADJ
ajlm-622	14	22	markers	marker	NOUN
ajlm-622	14	23	.	.	PUNCT
ajlm-622	15	1	introduction	introduction	NOUN
ajlm-622	15	2	hepatitis	hepatitis	PROPN
ajlm-622	15	3	b	b	PROPN
ajlm-622	15	4	virus	virus	NOUN
ajlm-622	15	5	(	(	PUNCT
ajlm-622	15	6	hbv	hbv	NOUN
ajlm-622	15	7	)	)	PUNCT
ajlm-622	15	8	,	,	PUNCT
ajlm-622	15	9	a	a	DET
ajlm-622	15	10	circular	circular	ADJ
ajlm-622	15	11	dna	dna	NOUN
ajlm-622	15	12	virus	virus	NOUN
ajlm-622	15	13	with	with	ADP
ajlm-622	15	14	humans	human	NOUN
ajlm-622	15	15	serving	serve	VERB
ajlm-622	15	16	as	as	ADP
ajlm-622	15	17	the	the	DET
ajlm-622	15	18	only	only	ADJ
ajlm-622	15	19	reservoir1	reservoir1	NOUN
ajlm-622	15	20	,	,	PUNCT
ajlm-622	15	21	remains	remain	VERB
ajlm-622	15	22	a	a	DET
ajlm-622	15	23	worldwide	worldwide	ADJ
ajlm-622	15	24	public	public	ADJ
ajlm-622	15	25	health	health	NOUN
ajlm-622	15	26	problem	problem	NOUN
ajlm-622	15	27	.	.	PUNCT
ajlm-622	16	1	transmission	transmission	NOUN
ajlm-622	16	2	of	of	ADP
ajlm-622	16	3	the	the	DET
ajlm-622	16	4	virus	virus	NOUN
ajlm-622	16	5	occurs	occur	VERB
ajlm-622	16	6	via	via	ADP
ajlm-622	16	7	exposure	exposure	NOUN
ajlm-622	16	8	to	to	ADP
ajlm-622	16	9	infected	infected	ADJ
ajlm-622	16	10	blood	blood	NOUN
ajlm-622	16	11	and	and	CCONJ
ajlm-622	16	12	body	body	NOUN
ajlm-622	16	13	fluids.1	fluids.1	INTJ
ajlm-622	16	14	in	in	ADP
ajlm-622	16	15	areas	area	NOUN
ajlm-622	16	16	where	where	SCONJ
ajlm-622	16	17	the	the	DET
ajlm-622	16	18	prevalence	prevalence	NOUN
ajlm-622	16	19	of	of	ADP
ajlm-622	16	20	hepatitis	hepatitis	PROPN
ajlm-622	16	21	b	b	PROPN
ajlm-622	16	22	surface	surface	NOUN
ajlm-622	16	23	antigen	antigen	NOUN
ajlm-622	16	24	(	(	PUNCT
ajlm-622	16	25	hbsag	hbsag	NOUN
ajlm-622	16	26	)	)	PUNCT
ajlm-622	16	27	is	be	AUX
ajlm-622	16	28	more	more	ADJ
ajlm-622	16	29	than	than	ADP
ajlm-622	16	30	8	8	NUM
ajlm-622	16	31	%	%	NOUN
ajlm-622	16	32	,	,	PUNCT
ajlm-622	16	33	there	there	PRON
ajlm-622	16	34	are	be	VERB
ajlm-622	16	35	two	two	NUM
ajlm-622	16	36	broad	broad	ADJ
ajlm-622	16	37	possibilities	possibility	NOUN
ajlm-622	16	38	for	for	ADP
ajlm-622	16	39	how	how	SCONJ
ajlm-622	16	40	transmission	transmission	NOUN
ajlm-622	16	41	can	can	AUX
ajlm-622	16	42	occur	occur	VERB
ajlm-622	16	43	:	:	PUNCT
ajlm-622	16	44	either	either	CCONJ
ajlm-622	16	45	it	it	PRON
ajlm-622	16	46	happens	happen	VERB
ajlm-622	16	47	vertically	vertically	ADV
ajlm-622	16	48	at	at	ADP
ajlm-622	16	49	birth	birth	NOUN
ajlm-622	16	50	from	from	ADP
ajlm-622	16	51	chronically	chronically	ADV
ajlm-622	16	52	infected	infect	VERB
ajlm-622	16	53	mothers	mother	NOUN
ajlm-622	16	54	to	to	ADP
ajlm-622	16	55	their	their	PRON
ajlm-622	16	56	newborns	newborn	NOUN
ajlm-622	16	57	or	or	CCONJ
ajlm-622	16	58	horizontally	horizontally	ADV
ajlm-622	16	59	during	during	ADP
ajlm-622	16	60	childhood	childhood	NOUN
ajlm-622	16	61	or	or	CCONJ
ajlm-622	16	62	in	in	ADP
ajlm-622	16	63	adulthood.2,3	adulthood.2,3	PROPN
ajlm-622	16	64	the	the	DET
ajlm-622	16	65	infection	infection	NOUN
ajlm-622	16	66	caused	cause	VERB
ajlm-622	16	67	by	by	ADP
ajlm-622	16	68	the	the	DET
ajlm-622	16	69	virus	virus	NOUN
ajlm-622	16	70	is	be	AUX
ajlm-622	16	71	among	among	ADP
ajlm-622	16	72	the	the	DET
ajlm-622	16	73	leading	lead	VERB
ajlm-622	16	74	causes	cause	NOUN
ajlm-622	16	75	of	of	ADP
ajlm-622	16	76	liver	liver	NOUN
ajlm-622	16	77	disease	disease	NOUN
ajlm-622	16	78	,	,	PUNCT
ajlm-622	16	79	with	with	ADP
ajlm-622	16	80	liver	liver	NOUN
ajlm-622	16	81	-	-	PUNCT
ajlm-622	16	82	related	relate	VERB
ajlm-622	16	83	deaths	death	NOUN
ajlm-622	16	84	occurring	occur	VERB
ajlm-622	16	85	in	in	ADP
ajlm-622	16	86	an	an	DET
ajlm-622	16	87	estimated	estimate	VERB
ajlm-622	16	88	25	25	NUM
ajlm-622	16	89	%	%	NOUN
ajlm-622	16	90	–	–	PUNCT
ajlm-622	16	91	30	30	NUM
ajlm-622	16	92	%	%	NOUN
ajlm-622	16	93	of	of	ADP
ajlm-622	16	94	the	the	DET
ajlm-622	16	95	population	population	NOUN
ajlm-622	16	96	of	of	ADP
ajlm-622	16	97	chronic	chronic	ADJ
ajlm-622	16	98	carriers	carrier	NOUN
ajlm-622	16	99	,	,	PUNCT
ajlm-622	16	100	principally	principally	ADV
ajlm-622	16	101	cirrhosis	cirrhosis	NOUN
ajlm-622	16	102	and	and	CCONJ
ajlm-622	16	103	hepatocellular	hepatocellular	NOUN
ajlm-622	16	104	carcinoma.4	carcinoma.4	PROPN
ajlm-622	16	105	a	a	DET
ajlm-622	16	106	fifth	fifth	NOUN
ajlm-622	16	107	of	of	ADP
ajlm-622	16	108	the	the	DET
ajlm-622	16	109	current	current	ADJ
ajlm-622	16	110	global	global	ADJ
ajlm-622	16	111	population	population	NOUN
ajlm-622	16	112	is	be	AUX
ajlm-622	16	113	estimated	estimate	VERB
ajlm-622	16	114	to	to	PART
ajlm-622	16	115	be	be	AUX
ajlm-622	16	116	seropositive	seropositive	ADJ
ajlm-622	16	117	for	for	ADP
ajlm-622	16	118	hbsag.5	hbsag.5	NOUN
ajlm-622	16	119	as	as	ADP
ajlm-622	16	120	at	at	ADP
ajlm-622	16	121	2013	2013	NUM
ajlm-622	16	122	,	,	PUNCT
ajlm-622	16	123	an	an	DET
ajlm-622	16	124	estimated	estimate	VERB
ajlm-622	16	125	13.6	13.6	NUM
ajlm-622	16	126	%	%	NOUN
ajlm-622	16	127	of	of	ADP
ajlm-622	16	128	the	the	DET
ajlm-622	16	129	nigerian	nigerian	ADJ
ajlm-622	16	130	population	population	NOUN
ajlm-622	16	131	had	have	AUX
ajlm-622	16	132	been	be	AUX
ajlm-622	16	133	reported	report	VERB
ajlm-622	16	134	to	to	PART
ajlm-622	16	135	be	be	AUX
ajlm-622	16	136	chronic	chronic	ADJ
ajlm-622	16	137	carriers	carrier	NOUN
ajlm-622	16	138	of	of	ADP
ajlm-622	16	139	hbsag.6	hbsag.6	PROPN
ajlm-622	16	140	consequently	consequently	ADV
ajlm-622	16	141	,	,	PUNCT
ajlm-622	16	142	the	the	DET
ajlm-622	16	143	burden	burden	NOUN
ajlm-622	16	144	of	of	ADP
ajlm-622	16	145	disease	disease	NOUN
ajlm-622	16	146	is	be	AUX
ajlm-622	16	147	considered	consider	VERB
ajlm-622	16	148	to	to	PART
ajlm-622	16	149	be	be	AUX
ajlm-622	16	150	high	high	ADJ
ajlm-622	16	151	,	,	PUNCT
ajlm-622	16	152	as	as	SCONJ
ajlm-622	16	153	evidenced	evidence	VERB
ajlm-622	16	154	by	by	ADP
ajlm-622	16	155	the	the	DET
ajlm-622	16	156	high	high	ADJ
ajlm-622	16	157	incidence	incidence	NOUN
ajlm-622	16	158	of	of	ADP
ajlm-622	16	159	morbidity	morbidity	NOUN
ajlm-622	16	160	and	and	CCONJ
ajlm-622	16	161	mortality	mortality	NOUN
ajlm-622	16	162	associated	associate	VERB
ajlm-622	16	163	with	with	ADP
ajlm-622	16	164	the	the	DET
ajlm-622	16	165	virus.7	virus.7	ADJ
ajlm-622	16	166	the	the	DET
ajlm-622	16	167	similarity	similarity	NOUN
ajlm-622	16	168	in	in	ADP
ajlm-622	16	169	transmission	transmission	NOUN
ajlm-622	16	170	routes	route	NOUN
ajlm-622	16	171	for	for	ADP
ajlm-622	16	172	hbv	hbv	NOUN
ajlm-622	16	173	and	and	CCONJ
ajlm-622	16	174	hiv	hiv	PROPN
ajlm-622	16	175	makes	make	VERB
ajlm-622	16	176	co	co	NOUN
ajlm-622	16	177	-	-	NOUN
ajlm-622	16	178	infection	infection	NOUN
ajlm-622	16	179	very	very	ADV
ajlm-622	16	180	common.8	common.8	PROPN
ajlm-622	16	181	hbv	hbv	NOUN
ajlm-622	16	182	/	/	SYM
ajlm-622	16	183	hiv	hiv	PROPN
ajlm-622	16	184	co	co	NOUN
ajlm-622	16	185	-	-	NOUN
ajlm-622	16	186	infection	infection	NOUN
ajlm-622	16	187	has	have	AUX
ajlm-622	16	188	been	be	AUX
ajlm-622	16	189	shown	show	VERB
ajlm-622	16	190	by	by	ADP
ajlm-622	16	191	some	some	DET
ajlm-622	16	192	studies	study	NOUN
ajlm-622	16	193	to	to	PART
ajlm-622	16	194	increase	increase	VERB
ajlm-622	16	195	morbidity	morbidity	NOUN
ajlm-622	16	196	and	and	CCONJ
ajlm-622	16	197	mortality	mortality	NOUN
ajlm-622	16	198	when	when	SCONJ
ajlm-622	16	199	compared	compare	VERB
ajlm-622	16	200	to	to	ADP
ajlm-622	16	201	hiv	hiv	PROPN
ajlm-622	16	202	mono	mono	PROPN
ajlm-622	16	203	-	-	PUNCT
ajlm-622	16	204	infection.9,10	infection.9,10	NOUN
ajlm-622	16	205	it	it	PRON
ajlm-622	16	206	has	have	AUX
ajlm-622	16	207	been	be	AUX
ajlm-622	16	208	reported	report	VERB
ajlm-622	16	209	that	that	SCONJ
ajlm-622	16	210	co	co	NOUN
ajlm-622	16	211	-	-	NOUN
ajlm-622	16	212	infection	infection	NOUN
ajlm-622	16	213	facilitates	facilitate	VERB
ajlm-622	16	214	replication	replication	NOUN
ajlm-622	16	215	and	and	CCONJ
ajlm-622	16	216	decreases	decrease	VERB
ajlm-622	16	217	clearance	clearance	NOUN
ajlm-622	16	218	of	of	ADP
ajlm-622	16	219	both	both	DET
ajlm-622	16	220	viruses	virus	NOUN
ajlm-622	16	221	,	,	PUNCT
ajlm-622	16	222	as	as	ADP
ajlm-622	16	223	a	a	DET
ajlm-622	16	224	result	result	NOUN
ajlm-622	16	225	of	of	ADP
ajlm-622	16	226	impaired	impaired	ADJ
ajlm-622	16	227	innate	innate	ADJ
ajlm-622	16	228	and	and	CCONJ
ajlm-622	16	229	adaptive	adaptive	ADJ
ajlm-622	16	230	immune	immune	ADJ
ajlm-622	16	231	responses.11,12	responses.11,12	NOUN
ajlm-622	16	232	the	the	DET
ajlm-622	16	233	hiv	hiv	PROPN
ajlm-622	16	234	-	-	PUNCT
ajlm-622	16	235	positive	positive	ADJ
ajlm-622	16	236	sub	sub	NOUN
ajlm-622	16	237	-	-	ADJ
ajlm-622	16	238	population	population	NOUN
ajlm-622	16	239	deserves	deserve	VERB
ajlm-622	16	240	attention	attention	NOUN
ajlm-622	16	241	,	,	PUNCT
ajlm-622	16	242	considering	consider	VERB
ajlm-622	16	243	the	the	DET
ajlm-622	16	244	enormous	enormous	ADJ
ajlm-622	16	245	public	public	ADJ
ajlm-622	16	246	health	health	NOUN
ajlm-622	16	247	consequences	consequence	NOUN
ajlm-622	16	248	that	that	PRON
ajlm-622	16	249	co	co	NOUN
ajlm-622	16	250	-	-	NOUN
ajlm-622	16	251	infection	infection	NOUN
ajlm-622	16	252	with	with	ADP
ajlm-622	16	253	hbv	hbv	NOUN
ajlm-622	16	254	can	can	AUX
ajlm-622	16	255	have	have	VERB
ajlm-622	16	256	.	.	PUNCT
ajlm-622	17	1	this	this	DET
ajlm-622	17	2	cross	cross	ADJ
ajlm-622	17	3	-	-	ADJ
ajlm-622	17	4	sectional	sectional	ADJ
ajlm-622	17	5	study	study	NOUN
ajlm-622	17	6	reports	report	VERB
ajlm-622	17	7	the	the	DET
ajlm-622	17	8	prevalence	prevalence	NOUN
ajlm-622	17	9	of	of	ADP
ajlm-622	17	10	hbv	hbv	NOUN
ajlm-622	17	11	infection	infection	NOUN
ajlm-622	17	12	among	among	ADP
ajlm-622	17	13	hiv	hiv	PROPN
ajlm-622	17	14	-	-	PUNCT
ajlm-622	17	15	positive	positive	ADJ
ajlm-622	17	16	patients	patient	NOUN
ajlm-622	17	17	receiving	receive	VERB
ajlm-622	17	18	treatment	treatment	NOUN
ajlm-622	17	19	and	and	CCONJ
ajlm-622	17	20	care	care	VERB
ajlm-622	17	21	from	from	ADP
ajlm-622	17	22	the	the	DET
ajlm-622	17	23	jos	jos	PROPN
ajlm-622	17	24	university	university	PROPN
ajlm-622	17	25	teaching	teaching	NOUN
ajlm-622	17	26	hospital	hospital	NOUN
ajlm-622	17	27	(	(	PUNCT
ajlm-622	17	28	juth	juth	NOUN
ajlm-622	17	29	)	)	PUNCT
ajlm-622	17	30	,	,	PUNCT
ajlm-622	17	31	infectious	infectious	ADJ
ajlm-622	17	32	diseases	disease	NOUN
ajlm-622	17	33	unit	unit	NOUN
ajlm-622	17	34	.	.	PUNCT
ajlm-622	18	1	methods	method	NOUN
ajlm-622	18	2	ethical	ethical	ADJ
ajlm-622	18	3	considerations	consideration	NOUN
ajlm-622	18	4	approval	approval	NOUN
ajlm-622	18	5	of	of	ADP
ajlm-622	18	6	the	the	DET
ajlm-622	18	7	study	study	NOUN
ajlm-622	18	8	protocol	protocol	NOUN
ajlm-622	18	9	was	be	AUX
ajlm-622	18	10	obtained	obtain	VERB
ajlm-622	18	11	from	from	ADP
ajlm-622	18	12	the	the	DET
ajlm-622	18	13	institutional	institutional	ADJ
ajlm-622	18	14	ethics	ethic	NOUN
ajlm-622	18	15	committee	committee	PROPN
ajlm-622	18	16	at	at	ADP
ajlm-622	18	17	juth	juth	NOUN
ajlm-622	18	18	(	(	PUNCT
ajlm-622	18	19	study	study	NOUN
ajlm-622	18	20	approval	approval	NOUN
ajlm-622	18	21	number	number	NOUN
ajlm-622	18	22	,	,	PUNCT
ajlm-622	18	23	juth	juth	NOUN
ajlm-622	18	24	/	/	SYM
ajlm-622	18	25	dcs	dcs	PROPN
ajlm-622	18	26	/	/	SYM
ajlm-622	18	27	adm/127	adm/127	PROPN
ajlm-622	18	28	/	/	SYM
ajlm-622	18	29	xix/5967	xix/5967	PROPN
ajlm-622	18	30	)	)	PUNCT
ajlm-622	18	31	.	.	PUNCT
ajlm-622	19	1	study	study	NOUN
ajlm-622	19	2	population	population	NOUN
ajlm-622	19	3	this	this	DET
ajlm-622	19	4	laboratory	laboratory	NOUN
ajlm-622	19	5	-	-	PUNCT
ajlm-622	19	6	based	base	VERB
ajlm-622	19	7	study	study	NOUN
ajlm-622	19	8	was	be	AUX
ajlm-622	19	9	carried	carry	VERB
ajlm-622	19	10	out	out	ADP
ajlm-622	19	11	by	by	ADP
ajlm-622	19	12	examining	examine	VERB
ajlm-622	19	13	120	120	NUM
ajlm-622	19	14	hiv	hiv	PROPN
ajlm-622	19	15	patients	patient	NOUN
ajlm-622	19	16	older	old	ADJ
ajlm-622	19	17	than	than	ADP
ajlm-622	19	18	18	18	NUM
ajlm-622	19	19	years	year	NOUN
ajlm-622	19	20	on	on	ADP
ajlm-622	19	21	highly	highly	ADV
ajlm-622	19	22	active	active	ADJ
ajlm-622	19	23	antiretroviral	antiretroviral	ADJ
ajlm-622	19	24	therapy	therapy	NOUN
ajlm-622	19	25	accessing	access	VERB
ajlm-622	19	26	care	care	NOUN
ajlm-622	19	27	at	at	ADP
ajlm-622	19	28	juth	juth	NOUN
ajlm-622	19	29	who	who	PRON
ajlm-622	19	30	provided	provide	VERB
ajlm-622	19	31	written	write	VERB
ajlm-622	19	32	informed	inform	VERB
ajlm-622	19	33	consent	consent	NOUN
ajlm-622	19	34	.	.	PUNCT
ajlm-622	20	1	the	the	DET
ajlm-622	20	2	sample	sample	NOUN
ajlm-622	20	3	size	size	NOUN
ajlm-622	20	4	was	be	AUX
ajlm-622	20	5	determined	determine	VERB
ajlm-622	20	6	using	use	VERB
ajlm-622	20	7	the	the	DET
ajlm-622	20	8	following	following	NOUN
ajlm-622	20	9	formula:13	formula:13	PUNCT
ajlm-622	21	1	where	where	SCONJ
ajlm-622	21	2	z	z	NOUN
ajlm-622	21	3	=	=	PUNCT
ajlm-622	21	4	alpha	alpha	NOUN
ajlm-622	21	5	at	at	ADP
ajlm-622	21	6	95	95	NUM
ajlm-622	21	7	%	%	NOUN
ajlm-622	21	8	confidence	confidence	NOUN
ajlm-622	21	9	level	level	NOUN
ajlm-622	21	10	=	=	NOUN
ajlm-622	21	11	1.96	1.96	NUM
ajlm-622	21	12	p	p	NOUN
ajlm-622	21	13	=	=	NOUN
ajlm-622	21	14	prevalence	prevalence	NOUN
ajlm-622	21	15	of	of	ADP
ajlm-622	21	16	hepatitis	hepatitis	PROPN
ajlm-622	21	17	b	b	PROPN
ajlm-622	21	18	virus	virus	NOUN
ajlm-622	21	19	infection14	infection14	VERB
ajlm-622	21	20	=	=	SYM
ajlm-622	21	21	7.2	7.2	NUM
ajlm-622	21	22	%	%	NOUN
ajlm-622	21	23	=	=	NOUN
ajlm-622	21	24	0.072	0.072	NUM
ajlm-622	21	25	q	q	NOUN
ajlm-622	22	1	=	=	SYM
ajlm-622	22	2	0.928	0.928	NUM
ajlm-622	22	3	e	e	X
ajlm-622	22	4	=	=	NOUN
ajlm-622	22	5	margin	margin	NOUN
ajlm-622	22	6	of	of	ADP
ajlm-622	22	7	error	error	NOUN
ajlm-622	22	8	=	=	NOUN
ajlm-622	22	9	0.05	0.05	NUM
ajlm-622	22	10	n	n	NOUN
ajlm-622	22	11	=	=	SYM
ajlm-622	22	12	minimum	minimum	NOUN
ajlm-622	22	13	sample	sample	NOUN
ajlm-622	22	14	size	size	NOUN
ajlm-622	22	15	=	=	NOUN
ajlm-622	22	16	10.2	10.2	NUM
ajlm-622	22	17	with	with	ADP
ajlm-622	22	18	10	10	NUM
ajlm-622	22	19	%	%	NOUN
ajlm-622	22	20	attrition	attrition	NOUN
ajlm-622	22	21	=	=	PROPN
ajlm-622	22	22	10.2	10.2	NUM
ajlm-622	22	23	,	,	PUNCT
ajlm-622	22	24	thus	thus	ADV
ajlm-622	22	25	n	n	CCONJ
ajlm-622	22	26	=	=	SYM
ajlm-622	22	27	20	20	NUM
ajlm-622	22	28	collection	collection	NOUN
ajlm-622	22	29	of	of	ADP
ajlm-622	22	30	patients	patient	NOUN
ajlm-622	22	31	’	’	PART
ajlm-622	22	32	blood	blood	NOUN
ajlm-622	22	33	whole	whole	ADJ
ajlm-622	22	34	blood	blood	NOUN
ajlm-622	22	35	samples	sample	NOUN
ajlm-622	22	36	were	be	AUX
ajlm-622	22	37	obtained	obtain	VERB
ajlm-622	22	38	from	from	ADP
ajlm-622	22	39	each	each	DET
ajlm-622	22	40	patient	patient	NOUN
ajlm-622	22	41	and	and	CCONJ
ajlm-622	22	42	used	use	VERB
ajlm-622	22	43	for	for	ADP
ajlm-622	22	44	screening	screen	VERB
ajlm-622	22	45	for	for	ADP
ajlm-622	22	46	hbv	hbv	NOUN
ajlm-622	22	47	serological	serological	ADJ
ajlm-622	22	48	markers	marker	NOUN
ajlm-622	22	49	as	as	ADV
ajlm-622	22	50	well	well	ADV
ajlm-622	22	51	as	as	ADP
ajlm-622	22	52	for	for	ADP
ajlm-622	22	53	performing	perform	VERB
ajlm-622	22	54	cluster	cluster	NOUN
ajlm-622	22	55	of	of	ADP
ajlm-622	22	56	differentiation	differentiation	NOUN
ajlm-622	22	57	cd4	cd4	PROPN
ajlm-622	22	58	+	+	PROPN
ajlm-622	22	59	t	t	PROPN
ajlm-622	22	60	-	-	PUNCT
ajlm-622	22	61	lymphocyte	lymphocyte	NOUN
ajlm-622	22	62	enumeration	enumeration	NOUN
ajlm-622	22	63	and	and	CCONJ
ajlm-622	22	64	clinical	clinical	ADJ
ajlm-622	22	65	chemistry	chemistry	NOUN
ajlm-622	22	66	analysis	analysis	NOUN
ajlm-622	22	67	of	of	ADP
ajlm-622	22	68	alanine	alanine	NOUN
ajlm-622	22	69	aminotransferase	aminotransferase	NOUN
ajlm-622	22	70	(	(	PUNCT
ajlm-622	22	71	alt	alt	ADJ
ajlm-622	22	72	)	)	PUNCT
ajlm-622	22	73	.	.	PUNCT
ajlm-622	23	1	the	the	DET
ajlm-622	23	2	process	process	NOUN
ajlm-622	23	3	involved	involve	VERB
ajlm-622	23	4	collection	collection	NOUN
ajlm-622	23	5	of	of	ADP
ajlm-622	23	6	blood	blood	NOUN
ajlm-622	23	7	using	use	VERB
ajlm-622	23	8	a	a	DET
ajlm-622	23	9	bd	bd	PROPN
ajlm-622	23	10	precision	precision	NOUN
ajlm-622	23	11	glide	glide	NOUN
ajlm-622	23	12	™	™	PUNCT
ajlm-622	23	13	into	into	ADP
ajlm-622	23	14	a	a	DET
ajlm-622	23	15	4	4	NUM
ajlm-622	23	16	ml	ml	NOUN
ajlm-622	23	17	edta	edta	NOUN
ajlm-622	23	18	bd	bd	PROPN
ajlm-622	23	19	vacutainer	vacutainer	ADJ
ajlm-622	23	20	®	®	PROPN
ajlm-622	23	21	(	(	PUNCT
ajlm-622	23	22	becton	becton	PROPN
ajlm-622	23	23	dickinson	dickinson	PROPN
ajlm-622	23	24	,	,	PUNCT
ajlm-622	23	25	plymouth	plymouth	PROPN
ajlm-622	23	26	,	,	PUNCT
ajlm-622	23	27	united	united	ADJ
ajlm-622	23	28	kingdom	kingdom	PROPN
ajlm-622	23	29	)	)	PUNCT
ajlm-622	23	30	for	for	ADP
ajlm-622	23	31	cd4	cd4	PROPN
ajlm-622	23	32	+	+	PROPN
ajlm-622	23	33	t	t	PROPN
ajlm-622	23	34	-	-	PUNCT
ajlm-622	23	35	lymphocyte	lymphocyte	NOUN
ajlm-622	23	36	enumeration	enumeration	NOUN
ajlm-622	23	37	and	and	CCONJ
ajlm-622	23	38	into	into	ADP
ajlm-622	23	39	a	a	DET
ajlm-622	23	40	6	6	NUM
ajlm-622	23	41	ml	ml	NOUN
ajlm-622	23	42	bd	bd	PROPN
ajlm-622	23	43	vacutainer	vacutainer	ADJ
ajlm-622	23	44	®	®	NOUN
ajlm-622	23	45	clot	clot	NOUN
ajlm-622	23	46	activator	activator	NOUN
ajlm-622	23	47	tube	tube	NOUN
ajlm-622	23	48	(	(	PUNCT
ajlm-622	23	49	becton	becton	PROPN
ajlm-622	23	50	dickinson	dickinson	PROPN
ajlm-622	23	51	,	,	PUNCT
ajlm-622	23	52	plymouth	plymouth	PROPN
ajlm-622	23	53	,	,	PUNCT
ajlm-622	23	54	united	united	ADJ
ajlm-622	23	55	kingdom	kingdom	PROPN
ajlm-622	23	56	)	)	PUNCT
ajlm-622	23	57	.	.	PUNCT
ajlm-622	24	1	serological	serological	ADJ
ajlm-622	24	2	marker	marker	NOUN
ajlm-622	24	3	assay	assay	NOUN
ajlm-622	24	4	plasma	plasma	NOUN
ajlm-622	24	5	was	be	AUX
ajlm-622	24	6	obtained	obtain	VERB
ajlm-622	24	7	by	by	ADP
ajlm-622	24	8	centrifuging	centrifuging	NOUN
ajlm-622	24	9	collected	collect	VERB
ajlm-622	24	10	whole	whole	ADJ
ajlm-622	24	11	blood	blood	NOUN
ajlm-622	24	12	at	at	ADP
ajlm-622	24	13	2500	2500	NUM
ajlm-622	24	14	rpm	rpm	NOUN
ajlm-622	24	15	for	for	ADP
ajlm-622	24	16	1	1	NUM
ajlm-622	24	17	min	min	NOUN
ajlm-622	24	18	and	and	CCONJ
ajlm-622	24	19	testing	testing	NOUN
ajlm-622	24	20	for	for	ADP
ajlm-622	24	21	hepatitis	hepatitis	PROPN
ajlm-622	24	22	b	b	PROPN
ajlm-622	24	23	serologic	serologic	NOUN
ajlm-622	24	24	markers	marker	NOUN
ajlm-622	24	25	,	,	PUNCT
ajlm-622	24	26	including	include	VERB
ajlm-622	24	27	the	the	DET
ajlm-622	24	28	surface	surface	NOUN
ajlm-622	24	29	antigen	antigen	NOUN
ajlm-622	24	30	(	(	PUNCT
ajlm-622	24	31	hbsag	hbsag	NOUN
ajlm-622	24	32	)	)	PUNCT
ajlm-622	24	33	,	,	PUNCT
ajlm-622	24	34	surface	surface	NOUN
ajlm-622	24	35	antibody	antibody	NOUN
ajlm-622	24	36	(	(	PUNCT
ajlm-622	24	37	anti	anti	X
ajlm-622	24	38	hbs	hbs	PROPN
ajlm-622	24	39	)	)	PUNCT
ajlm-622	24	40	,	,	PUNCT
ajlm-622	24	41	envelope	envelope	VERB
ajlm-622	24	42	antigen	antigen	NOUN
ajlm-622	24	43	(	(	PUNCT
ajlm-622	24	44	hbeag	hbeag	NOUN
ajlm-622	24	45	)	)	PUNCT
ajlm-622	24	46	,	,	PUNCT
ajlm-622	24	47	envelope	envelope	NOUN
ajlm-622	24	48	antibody	antibody	NOUN
ajlm-622	24	49	(	(	PUNCT
ajlm-622	24	50	anti	anti	X
ajlm-622	24	51	hbe	hbe	X
ajlm-622	24	52	)	)	PUNCT
ajlm-622	24	53	and	and	CCONJ
ajlm-622	24	54	core	core	NOUN
ajlm-622	24	55	antibody	antibody	NOUN
ajlm-622	24	56	(	(	PUNCT
ajlm-622	24	57	anti	anti	X
ajlm-622	24	58	hbc	hbc	PROPN
ajlm-622	24	59	)	)	PUNCT
ajlm-622	24	60	of	of	ADP
ajlm-622	24	61	viral	viral	ADJ
ajlm-622	24	62	particles	particle	NOUN
ajlm-622	24	63	as	as	SCONJ
ajlm-622	24	64	performed	perform	VERB
ajlm-622	24	65	using	use	VERB
ajlm-622	24	66	the	the	DET
ajlm-622	24	67	rapid	rapid	ADJ
ajlm-622	24	68	hbv	hbv	NOUN
ajlm-622	24	69	combo	combo	PROPN
ajlm-622	24	70	test	test	NOUN
ajlm-622	24	71	kit	kit	NOUN
ajlm-622	24	72	(	(	PUNCT
ajlm-622	24	73	acumen	acuman	NOUN
ajlm-622	24	74	diagnostics	diagnostic	NOUN
ajlm-622	24	75	incorporated	incorporate	VERB
ajlm-622	24	76	,	,	PUNCT
ajlm-622	24	77	china	china	PROPN
ajlm-622	24	78	)	)	PUNCT
ajlm-622	24	79	according	accord	VERB
ajlm-622	24	80	to	to	ADP
ajlm-622	24	81	the	the	DET
ajlm-622	24	82	manufacturer	manufacturer	NOUN
ajlm-622	24	83	’s	’s	PART
ajlm-622	24	84	instructions	instruction	NOUN
ajlm-622	24	85	.	.	PUNCT
ajlm-622	25	1	cd4	cd4	PROPN
ajlm-622	25	2	+	+	PROPN
ajlm-622	25	3	t	t	PROPN
ajlm-622	25	4	-	-	PUNCT
ajlm-622	25	5	lymphocyte	lymphocyte	NOUN
ajlm-622	25	6	enumeration	enumeration	NOUN
ajlm-622	25	7	cd4	cd4	PROPN
ajlm-622	25	8	+	+	PROPN
ajlm-622	25	9	t	t	PROPN
ajlm-622	25	10	-	-	PUNCT
ajlm-622	25	11	lymphocyte	lymphocyte	NOUN
ajlm-622	25	12	counts	count	NOUN
ajlm-622	25	13	for	for	ADP
ajlm-622	25	14	each	each	DET
ajlm-622	25	15	patient	patient	NOUN
ajlm-622	25	16	were	be	AUX
ajlm-622	25	17	obtained	obtain	VERB
ajlm-622	25	18	by	by	ADP
ajlm-622	25	19	adding	add	VERB
ajlm-622	25	20	20	20	NUM
ajlm-622	25	21	µl	µl	NOUN
ajlm-622	25	22	of	of	ADP
ajlm-622	25	23	the	the	DET
ajlm-622	25	24	patient	patient	NOUN
ajlm-622	25	25	’s	’s	PART
ajlm-622	25	26	whole	whole	ADJ
ajlm-622	25	27	blood	blood	NOUN
ajlm-622	25	28	to	to	ADP
ajlm-622	25	29	20	20	NUM
ajlm-622	25	30	µl	µl	NOUN
ajlm-622	25	31	of	of	ADP
ajlm-622	25	32	cd4	cd4	PROPN
ajlm-622	25	33	+	+	CCONJ
ajlm-622	25	34	easy	easy	ADJ
ajlm-622	25	35	count	count	NOUN
ajlm-622	25	36	kit	kit	NOUN
ajlm-622	25	37	monoclonal	monoclonal	NOUN
ajlm-622	25	38	antibody	antibody	NOUN
ajlm-622	25	39	,	,	PUNCT
ajlm-622	25	40	then	then	ADV
ajlm-622	25	41	incubating	incubate	VERB
ajlm-622	25	42	in	in	ADP
ajlm-622	25	43	the	the	DET
ajlm-622	25	44	dark	dark	NOUN
ajlm-622	25	45	for	for	ADP
ajlm-622	25	46	15	15	NUM
ajlm-622	25	47	min	min	NOUN
ajlm-622	25	48	.	.	PROPN
ajlm-622	25	49	afterwards	afterwards	ADV
ajlm-622	25	50	,	,	PUNCT
ajlm-622	25	51	800	800	NUM
ajlm-622	25	52	µl	µl	NOUN
ajlm-622	25	53	of	of	ADP
ajlm-622	25	54	cd4	cd4	PROPN
ajlm-622	25	55	+	+	CCONJ
ajlm-622	25	56	easy	easy	ADJ
ajlm-622	25	57	count	count	NOUN
ajlm-622	25	58	kit	kit	NOUN
ajlm-622	25	59	no	no	DET
ajlm-622	25	60	lyse	lyse	NOUN
ajlm-622	25	61	buffer	buffer	NOUN
ajlm-622	25	62	was	be	AUX
ajlm-622	25	63	added	add	VERB
ajlm-622	25	64	to	to	ADP
ajlm-622	25	65	the	the	DET
ajlm-622	25	66	incubated	incubate	VERB
ajlm-622	25	67	mixture	mixture	NOUN
ajlm-622	25	68	and	and	CCONJ
ajlm-622	25	69	analysed	analyse	VERB
ajlm-622	25	70	using	use	VERB
ajlm-622	25	71	a	a	DET
ajlm-622	25	72	partec	partec	ADJ
ajlm-622	25	73	cyflow	cyflow	NOUN
ajlm-622	25	74	cytometer	cytometer	NOUN
ajlm-622	25	75	(	(	PUNCT
ajlm-622	25	76	sysmex	sysmex	NOUN
ajlm-622	25	77	-	-	PUNCT
ajlm-622	25	78	partec	partec	NOUN
ajlm-622	25	79	,	,	PUNCT
ajlm-622	25	80	munster	munster	PROPN
ajlm-622	25	81	,	,	PUNCT
ajlm-622	25	82	germany	germany	PROPN
ajlm-622	25	83	)	)	PUNCT
ajlm-622	25	84	.	.	PUNCT
ajlm-622	26	1	evaluation	evaluation	NOUN
ajlm-622	26	2	of	of	ADP
ajlm-622	26	3	alanine	alanine	NOUN
ajlm-622	26	4	aminotransferase	aminotransferase	PROPN
ajlm-622	26	5	alt	alt	PROPN
ajlm-622	26	6	levels	level	NOUN
ajlm-622	26	7	were	be	AUX
ajlm-622	26	8	obtained	obtain	VERB
ajlm-622	26	9	using	use	VERB
ajlm-622	26	10	a	a	DET
ajlm-622	26	11	cobas	cobas	ADJ
ajlm-622	26	12	c311	c311	PROPN
ajlm-622	26	13	(	(	PUNCT
ajlm-622	26	14	roche	roche	NOUN
ajlm-622	26	15	diagnostics	diagnostic	NOUN
ajlm-622	26	16	,	,	PUNCT
ajlm-622	26	17	mannheim	mannheim	PROPN
ajlm-622	26	18	,	,	PUNCT
ajlm-622	26	19	germany	germany	PROPN
ajlm-622	26	20	)	)	PUNCT
ajlm-622	26	21	chemistry	chemistry	NOUN
ajlm-622	26	22	auto	auto	NOUN
ajlm-622	26	23	-	-	PUNCT
ajlm-622	26	24	analyser	analyser	NOUN
ajlm-622	26	25	.	.	PUNCT
ajlm-622	27	1	the	the	DET
ajlm-622	27	2	method	method	NOUN
ajlm-622	27	3	involved	involve	VERB
ajlm-622	27	4	using	use	VERB
ajlm-622	27	5	an	an	DET
ajlm-622	27	6	eppendorf	eppendorf	NOUN
ajlm-622	27	7	5708	5708	NUM
ajlm-622	27	8	centrifuge	centrifuge	NOUN
ajlm-622	27	9	to	to	PART
ajlm-622	27	10	spin	spin	VERB
ajlm-622	27	11	the	the	DET
ajlm-622	27	12	blood	blood	NOUN
ajlm-622	27	13	sample	sample	NOUN
ajlm-622	27	14	and	and	CCONJ
ajlm-622	27	15	obtain	obtain	VERB
ajlm-622	27	16	an	an	DET
ajlm-622	27	17	aliquot	aliquot	NOUN
ajlm-622	27	18	of	of	ADP
ajlm-622	27	19	serum	serum	NOUN
ajlm-622	27	20	,	,	PUNCT
ajlm-622	27	21	which	which	PRON
ajlm-622	27	22	was	be	AUX
ajlm-622	27	23	then	then	ADV
ajlm-622	27	24	placed	place	VERB
ajlm-622	27	25	in	in	ADP
ajlm-622	27	26	a	a	DET
ajlm-622	27	27	sample	sample	NOUN
ajlm-622	27	28	cup	cup	NOUN
ajlm-622	27	29	and	and	CCONJ
ajlm-622	27	30	processed	process	VERB
ajlm-622	27	31	using	use	VERB
ajlm-622	27	32	the	the	DET
ajlm-622	27	33	cobas	cobas	PROPN
ajlm-622	27	34	c311	c311	PROPN
ajlm-622	27	35	auto	auto	NOUN
ajlm-622	27	36	-	-	PUNCT
ajlm-622	27	37	analyser	analyser	NOUN
ajlm-622	27	38	to	to	PART
ajlm-622	27	39	determine	determine	VERB
ajlm-622	27	40	the	the	DET
ajlm-622	27	41	serum	serum	NOUN
ajlm-622	27	42	alt	alt	PROPN
ajlm-622	27	43	levels	level	NOUN
ajlm-622	27	44	of	of	ADP
ajlm-622	27	45	patients	patient	NOUN
ajlm-622	27	46	.	.	PUNCT
ajlm-622	28	1	data	datum	NOUN
ajlm-622	28	2	analysis	analysis	NOUN
ajlm-622	28	3	data	datum	NOUN
ajlm-622	28	4	were	be	AUX
ajlm-622	28	5	analysed	analyse	VERB
ajlm-622	28	6	using	use	VERB
ajlm-622	28	7	spss	spss	PROPN
ajlm-622	28	8	version	version	NOUN
ajlm-622	28	9	17	17	NUM
ajlm-622	28	10	(	(	PUNCT
ajlm-622	28	11	ibm	ibm	PROPN
ajlm-622	28	12	corporation	corporation	PROPN
ajlm-622	28	13	,	,	PUNCT
ajlm-622	28	14	armonk	armonk	PROPN
ajlm-622	28	15	,	,	PUNCT
ajlm-622	28	16	new	new	PROPN
ajlm-622	28	17	york	york	PROPN
ajlm-622	28	18	,	,	PUNCT
ajlm-622	28	19	united	united	PROPN
ajlm-622	28	20	states	states	PROPN
ajlm-622	28	21	)	)	PUNCT
ajlm-622	28	22	to	to	PART
ajlm-622	28	23	obtain	obtain	VERB
ajlm-622	28	24	descriptive	descriptive	ADJ
ajlm-622	28	25	statistics	statistic	NOUN
ajlm-622	28	26	,	,	PUNCT
ajlm-622	28	27	evaluate	evaluate	VERB
ajlm-622	28	28	associations	association	NOUN
ajlm-622	28	29	between	between	ADP
ajlm-622	28	30	socio	socio	NOUN
ajlm-622	28	31	-	-	ADJ
ajlm-622	28	32	demographic	demographic	ADJ
ajlm-622	28	33	variables	variable	NOUN
ajlm-622	28	34	and	and	CCONJ
ajlm-622	28	35	positivity	positivity	NOUN
ajlm-622	28	36	for	for	ADP
ajlm-622	28	37	hbv	hbv	NOUN
ajlm-622	28	38	.	.	PUNCT
ajlm-622	29	1	we	we	PRON
ajlm-622	29	2	also	also	ADV
ajlm-622	29	3	determined	determine	VERB
ajlm-622	29	4	whether	whether	SCONJ
ajlm-622	29	5	there	there	PRON
ajlm-622	29	6	was	be	VERB
ajlm-622	29	7	a	a	DET
ajlm-622	29	8	difference	difference	NOUN
ajlm-622	29	9	between	between	ADP
ajlm-622	29	10	alt	alt	NOUN
ajlm-622	29	11	and	and	CCONJ
ajlm-622	29	12	cd4	cd4	PROPN
ajlm-622	29	13	+	+	PROPN
ajlm-622	29	14	counts	count	NOUN
ajlm-622	29	15	using	use	VERB
ajlm-622	29	16	an	an	DET
ajlm-622	29	17	unpaired	unpaired	ADJ
ajlm-622	29	18	t	t	NOUN
ajlm-622	29	19	-	-	PUNCT
ajlm-622	29	20	test	test	NOUN
ajlm-622	29	21	for	for	ADP
ajlm-622	29	22	the	the	DET
ajlm-622	29	23	mean	mean	ADJ
ajlm-622	29	24	values	value	NOUN
ajlm-622	29	25	of	of	ADP
ajlm-622	29	26	both	both	DET
ajlm-622	29	27	groups	group	NOUN
ajlm-622	29	28	.	.	PUNCT
ajlm-622	30	1	decisions	decision	NOUN
ajlm-622	30	2	on	on	ADP
ajlm-622	30	3	statistical	statistical	ADJ
ajlm-622	30	4	significance	significance	NOUN
ajlm-622	30	5	were	be	AUX
ajlm-622	30	6	made	make	VERB
ajlm-622	30	7	at	at	ADP
ajlm-622	30	8	a	a	DET
ajlm-622	30	9	5	5	NUM
ajlm-622	30	10	%	%	NOUN
ajlm-622	30	11	level	level	NOUN
ajlm-622	30	12	of	of	ADP
ajlm-622	30	13	significance	significance	NOUN
ajlm-622	30	14	.	.	PUNCT
ajlm-622	31	1	results	result	NOUN
ajlm-622	31	2	out	out	ADP
ajlm-622	31	3	of	of	ADP
ajlm-622	31	4	the	the	DET
ajlm-622	31	5	120	120	NUM
ajlm-622	31	6	patients	patient	NOUN
ajlm-622	31	7	on	on	ADP
ajlm-622	31	8	highly	highly	ADV
ajlm-622	31	9	active	active	ADJ
ajlm-622	31	10	antiretroviral	antiretroviral	ADJ
ajlm-622	31	11	treatment	treatment	NOUN
ajlm-622	31	12	who	who	PRON
ajlm-622	31	13	participated	participate	VERB
ajlm-622	31	14	in	in	ADP
ajlm-622	31	15	the	the	DET
ajlm-622	31	16	study	study	NOUN
ajlm-622	31	17	,	,	PUNCT
ajlm-622	31	18	88	88	NUM
ajlm-622	31	19	(	(	PUNCT
ajlm-622	31	20	73.3	73.3	NUM
ajlm-622	31	21	%	%	NOUN
ajlm-622	31	22	)	)	PUNCT
ajlm-622	31	23	were	be	AUX
ajlm-622	31	24	women	woman	NOUN
ajlm-622	31	25	and	and	CCONJ
ajlm-622	31	26	32	32	NUM
ajlm-622	31	27	(	(	PUNCT
ajlm-622	31	28	26.7	26.7	NUM
ajlm-622	31	29	%	%	NOUN
ajlm-622	31	30	)	)	PUNCT
ajlm-622	31	31	were	be	AUX
ajlm-622	31	32	men	man	NOUN
ajlm-622	31	33	(	(	PUNCT
ajlm-622	31	34	table	table	NOUN
ajlm-622	31	35	1	1	NUM
ajlm-622	31	36	)	)	PUNCT
ajlm-622	31	37	.	.	PUNCT
ajlm-622	32	1	participants	participant	NOUN
ajlm-622	32	2	in	in	ADP
ajlm-622	32	3	this	this	DET
ajlm-622	32	4	study	study	NOUN
ajlm-622	32	5	had	have	VERB
ajlm-622	32	6	a	a	DET
ajlm-622	32	7	mean	mean	ADJ
ajlm-622	32	8	age	age	NOUN
ajlm-622	32	9	of	of	ADP
ajlm-622	32	10	40.4	40.4	NUM
ajlm-622	32	11	±	±	NUM
ajlm-622	32	12	10.6	10.6	NUM
ajlm-622	32	13	years	year	NOUN
ajlm-622	32	14	with	with	ADP
ajlm-622	32	15	male	male	ADJ
ajlm-622	32	16	participants	participant	NOUN
ajlm-622	32	17	significantly	significantly	ADV
ajlm-622	32	18	older	old	ADJ
ajlm-622	32	19	than	than	ADP
ajlm-622	32	20	their	their	PRON
ajlm-622	32	21	female	female	ADJ
ajlm-622	32	22	counterparts	counterpart	NOUN
ajlm-622	32	23	in	in	ADP
ajlm-622	32	24	the	the	DET
ajlm-622	32	25	study	study	NOUN
ajlm-622	32	26	.	.	PUNCT
ajlm-622	33	1	similarly	similarly	ADV
ajlm-622	33	2	,	,	PUNCT
ajlm-622	33	3	the	the	DET
ajlm-622	33	4	alt	alt	ADJ
ajlm-622	33	5	levels	level	NOUN
ajlm-622	33	6	of	of	ADP
ajlm-622	33	7	male	male	ADJ
ajlm-622	33	8	participants	participant	NOUN
ajlm-622	33	9	were	be	AUX
ajlm-622	33	10	significantly	significantly	ADV
ajlm-622	33	11	higher	high	ADJ
ajlm-622	33	12	than	than	ADP
ajlm-622	33	13	female	female	ADJ
ajlm-622	33	14	participants	participant	NOUN
ajlm-622	33	15	.	.	PUNCT
ajlm-622	34	1	table	table	NOUN
ajlm-622	34	2	1	1	NUM
ajlm-622	34	3	:	:	PUNCT
ajlm-622	34	4	 	 	SPACE
ajlm-622	34	5	patient	patient	ADJ
ajlm-622	34	6	characteristics	characteristic	NOUN
ajlm-622	34	7	by	by	ADP
ajlm-622	34	8	sex	sex	NOUN
ajlm-622	34	9	,	,	PUNCT
ajlm-622	34	10	jos	jos	PROPN
ajlm-622	34	11	university	university	PROPN
ajlm-622	34	12	teaching	teaching	NOUN
ajlm-622	34	13	hospital	hospital	NOUN
ajlm-622	34	14	hiv	hiv	PROPN
ajlm-622	34	15	clinic	clinic	PROPN
ajlm-622	34	16	,	,	PUNCT
ajlm-622	34	17	august	august	PROPN
ajlm-622	34	18	2015	2015	NUM
ajlm-622	34	19	.	.	PUNCT
ajlm-622	35	1	among	among	ADP
ajlm-622	35	2	the	the	DET
ajlm-622	35	3	hiv	hiv	PROPN
ajlm-622	35	4	-	-	PUNCT
ajlm-622	35	5	positive	positive	ADJ
ajlm-622	35	6	patients	patient	NOUN
ajlm-622	35	7	in	in	ADP
ajlm-622	35	8	the	the	DET
ajlm-622	35	9	study	study	NOUN
ajlm-622	35	10	,	,	PUNCT
ajlm-622	35	11	11	11	NUM
ajlm-622	35	12	were	be	AUX
ajlm-622	35	13	positive	positive	ADJ
ajlm-622	35	14	for	for	ADP
ajlm-622	35	15	hbsag	hbsag	NOUN
ajlm-622	35	16	(	(	PUNCT
ajlm-622	35	17	9.2	9.2	NUM
ajlm-622	35	18	%	%	NOUN
ajlm-622	35	19	)	)	PUNCT
ajlm-622	35	20	(	(	PUNCT
ajlm-622	35	21	table	table	NOUN
ajlm-622	35	22	2	2	NUM
ajlm-622	35	23	)	)	PUNCT
ajlm-622	35	24	.	.	PUNCT
ajlm-622	36	1	for	for	ADP
ajlm-622	36	2	the	the	DET
ajlm-622	36	3	other	other	ADJ
ajlm-622	36	4	serological	serological	ADJ
ajlm-622	36	5	markers	marker	NOUN
ajlm-622	36	6	in	in	ADP
ajlm-622	36	7	the	the	DET
ajlm-622	36	8	study	study	NOUN
ajlm-622	36	9	,	,	PUNCT
ajlm-622	36	10	15	15	NUM
ajlm-622	36	11	patients	patient	NOUN
ajlm-622	36	12	(	(	PUNCT
ajlm-622	36	13	12.5	12.5	NUM
ajlm-622	36	14	%	%	NOUN
ajlm-622	36	15	)	)	PUNCT
ajlm-622	36	16	were	be	AUX
ajlm-622	36	17	positive	positive	ADJ
ajlm-622	36	18	for	for	SCONJ
ajlm-622	36	19	anti	anti	PROPN
ajlm-622	36	20	hbs	hbs	PROPN
ajlm-622	36	21	1	1	NUM
ajlm-622	36	22	patient	patient	NOUN
ajlm-622	36	23	(	(	PUNCT
ajlm-622	36	24	0.8	0.8	NUM
ajlm-622	36	25	%	%	NOUN
ajlm-622	36	26	)	)	PUNCT
ajlm-622	36	27	was	be	AUX
ajlm-622	36	28	positive	positive	ADJ
ajlm-622	36	29	for	for	ADP
ajlm-622	36	30	hbeag	hbeag	NOUN
ajlm-622	36	31	,	,	PUNCT
ajlm-622	36	32	27	27	NUM
ajlm-622	36	33	patients	patient	NOUN
ajlm-622	36	34	(	(	PUNCT
ajlm-622	36	35	22.5	22.5	NUM
ajlm-622	36	36	%	%	NOUN
ajlm-622	36	37	)	)	PUNCT
ajlm-622	36	38	were	be	AUX
ajlm-622	36	39	positive	positive	ADJ
ajlm-622	36	40	for	for	ADP
ajlm-622	36	41	anti	anti	X
ajlm-622	36	42	hbe	hbe	X
ajlm-622	36	43	,	,	PUNCT
ajlm-622	36	44	and	and	CCONJ
ajlm-622	36	45	32	32	NUM
ajlm-622	36	46	patients	patient	NOUN
ajlm-622	36	47	(	(	PUNCT
ajlm-622	36	48	26.7	26.7	NUM
ajlm-622	36	49	%	%	NOUN
ajlm-622	36	50	)	)	PUNCT
ajlm-622	36	51	were	be	AUX
ajlm-622	36	52	positive	positive	ADJ
ajlm-622	36	53	for	for	ADP
ajlm-622	36	54	anti	anti	ADJ
ajlm-622	36	55	hbc	hbc	PROPN
ajlm-622	36	56	.	.	PUNCT
ajlm-622	36	57	table	table	NOUN
ajlm-622	36	58	2	2	NUM
ajlm-622	36	59	:	:	PUNCT
ajlm-622	36	60	 	 	SPACE
ajlm-622	36	61	seroprevalence	seroprevalence	NOUN
ajlm-622	36	62	of	of	ADP
ajlm-622	36	63	hepatitis	hepatitis	PROPN
ajlm-622	36	64	b	b	PROPN
ajlm-622	36	65	serological	serological	ADJ
ajlm-622	36	66	markers	marker	NOUN
ajlm-622	36	67	?	?	PUNCT
ajlm-622	37	1	among	among	ADP
ajlm-622	37	2	hiv	hiv	PROPN
ajlm-622	37	3	-	-	PUNCT
ajlm-622	37	4	positive	positive	ADJ
ajlm-622	37	5	adult	adult	NOUN
ajlm-622	37	6	patients	patient	NOUN
ajlm-622	37	7	attending	attend	VERB
ajlm-622	37	8	the	the	DET
ajlm-622	37	9	jos	jos	PROPN
ajlm-622	37	10	university	university	PROPN
ajlm-622	37	11	teaching	teaching	NOUN
ajlm-622	37	12	hospital	hospital	NOUN
ajlm-622	37	13	hiv	hiv	PROPN
ajlm-622	37	14	clinic	clinic	PROPN
ajlm-622	37	15	,	,	PUNCT
ajlm-622	37	16	august	august	PROPN
ajlm-622	37	17	2015	2015	NUM
ajlm-622	37	18	.	.	PUNCT
ajlm-622	38	1	being	be	AUX
ajlm-622	38	2	in	in	ADP
ajlm-622	38	3	the	the	DET
ajlm-622	38	4	40–49	40–49	NUM
ajlm-622	38	5	-	-	PUNCT
ajlm-622	38	6	year	year	NOUN
ajlm-622	38	7	age	age	NOUN
ajlm-622	38	8	group	group	NOUN
ajlm-622	38	9	was	be	AUX
ajlm-622	38	10	significantly	significantly	ADV
ajlm-622	38	11	associated	associate	VERB
ajlm-622	38	12	with	with	ADP
ajlm-622	38	13	hbv	hbv	PROPN
ajlm-622	38	14	/	/	SYM
ajlm-622	38	15	hiv	hiv	PROPN
ajlm-622	38	16	co	co	NOUN
ajlm-622	38	17	-	-	NOUN
ajlm-622	38	18	infection	infection	NOUN
ajlm-622	38	19	(	(	PUNCT
ajlm-622	38	20	p	p	X
ajlm-622	38	21	=	=	NOUN
ajlm-622	38	22	0.019	0.019	NUM
ajlm-622	38	23	)	)	PUNCT
ajlm-622	38	24	(	(	PUNCT
ajlm-622	38	25	table	table	NOUN
ajlm-622	38	26	3	3	NUM
ajlm-622	38	27	)	)	PUNCT
ajlm-622	38	28	.	.	PUNCT
ajlm-622	39	1	our	our	PRON
ajlm-622	39	2	study	study	NOUN
ajlm-622	39	3	reported	report	VERB
ajlm-622	39	4	a	a	DET
ajlm-622	39	5	higher	high	ADJ
ajlm-622	39	6	rate	rate	NOUN
ajlm-622	39	7	of	of	ADP
ajlm-622	39	8	hbv	hbv	NOUN
ajlm-622	39	9	infection	infection	NOUN
ajlm-622	39	10	among	among	ADP
ajlm-622	39	11	the	the	DET
ajlm-622	39	12	male	male	ADJ
ajlm-622	39	13	hiv	hiv	PROPN
ajlm-622	39	14	patients	patient	NOUN
ajlm-622	39	15	(	(	PUNCT
ajlm-622	39	16	12.0	12.0	NUM
ajlm-622	39	17	%	%	NOUN
ajlm-622	39	18	versus	versus	ADP
ajlm-622	39	19	7.9	7.9	NUM
ajlm-622	39	20	%	%	NOUN
ajlm-622	39	21	in	in	ADP
ajlm-622	39	22	female	female	ADJ
ajlm-622	39	23	patients	patient	NOUN
ajlm-622	39	24	)	)	PUNCT
ajlm-622	39	25	,	,	PUNCT
ajlm-622	39	26	but	but	CCONJ
ajlm-622	39	27	this	this	DET
ajlm-622	39	28	observation	observation	NOUN
ajlm-622	39	29	was	be	AUX
ajlm-622	39	30	not	not	PART
ajlm-622	39	31	significant	significant	ADJ
ajlm-622	39	32	(	(	PUNCT
ajlm-622	39	33	p	p	X
ajlm-622	39	34	=	=	NOUN
ajlm-622	39	35	0.494	0.494	NUM
ajlm-622	39	36	)	)	PUNCT
ajlm-622	39	37	.	.	PUNCT
ajlm-622	40	1	the	the	DET
ajlm-622	40	2	associations	association	NOUN
ajlm-622	40	3	of	of	ADP
ajlm-622	40	4	hbv	hbv	NOUN
ajlm-622	40	5	infection	infection	NOUN
ajlm-622	40	6	with	with	ADP
ajlm-622	40	7	age	age	NOUN
ajlm-622	40	8	,	,	PUNCT
ajlm-622	40	9	educational	educational	ADJ
ajlm-622	40	10	level	level	NOUN
ajlm-622	40	11	and	and	CCONJ
ajlm-622	40	12	marital	marital	ADJ
ajlm-622	40	13	status	status	NOUN
ajlm-622	40	14	were	be	AUX
ajlm-622	40	15	also	also	ADV
ajlm-622	40	16	not	not	PART
ajlm-622	40	17	statistically	statistically	ADV
ajlm-622	40	18	significant	significant	ADJ
ajlm-622	40	19	.	.	PUNCT
ajlm-622	41	1	no	no	DET
ajlm-622	41	2	association	association	NOUN
ajlm-622	41	3	between	between	ADP
ajlm-622	41	4	infection	infection	NOUN
ajlm-622	41	5	and	and	CCONJ
ajlm-622	41	6	marital	marital	ADJ
ajlm-622	41	7	status	status	NOUN
ajlm-622	41	8	(	(	PUNCT
ajlm-622	41	9	p	p	X
ajlm-622	41	10	=	=	NOUN
ajlm-622	41	11	0.875	0.875	NUM
ajlm-622	41	12	)	)	PUNCT
ajlm-622	41	13	when	when	SCONJ
ajlm-622	41	14	they	they	PRON
ajlm-622	41	15	were	be	AUX
ajlm-622	41	16	compared	compare	VERB
ajlm-622	41	17	to	to	ADP
ajlm-622	41	18	patients	patient	NOUN
ajlm-622	41	19	who	who	PRON
ajlm-622	41	20	were	be	AUX
ajlm-622	41	21	negative	negative	ADJ
ajlm-622	41	22	for	for	ADP
ajlm-622	41	23	hbsag	hbsag	NOUN
ajlm-622	41	24	.	.	PUNCT
ajlm-622	42	1	table	table	NOUN
ajlm-622	42	2	3	3	NUM
ajlm-622	42	3	:	:	PUNCT
ajlm-622	42	4	 	 	SPACE
ajlm-622	42	5	socio	socio	NOUN
ajlm-622	42	6	-	-	ADJ
ajlm-622	42	7	demographic	demographic	ADJ
ajlm-622	42	8	characteristics	characteristic	NOUN
ajlm-622	42	9	and	and	CCONJ
ajlm-622	42	10	laboratory	laboratory	NOUN
ajlm-622	42	11	parameters	parameter	NOUN
ajlm-622	42	12	of	of	ADP
ajlm-622	42	13	hbv	hbv	NOUN
ajlm-622	42	14	infection	infection	NOUN
ajlm-622	42	15	among	among	ADP
ajlm-622	42	16	hiv	hiv	PROPN
ajlm-622	42	17	-	-	PUNCT
ajlm-622	42	18	positive	positive	ADJ
ajlm-622	42	19	adult	adult	NOUN
ajlm-622	42	20	patients	patient	NOUN
ajlm-622	42	21	,	,	PUNCT
ajlm-622	42	22	jos	jos	PROPN
ajlm-622	42	23	university	university	PROPN
ajlm-622	42	24	teaching	teaching	NOUN
ajlm-622	42	25	hospital	hospital	NOUN
ajlm-622	42	26	hiv	hiv	PROPN
ajlm-622	42	27	clinic	clinic	PROPN
ajlm-622	42	28	,	,	PUNCT
ajlm-622	42	29	august	august	PROPN
ajlm-622	42	30	2015	2015	NUM
ajlm-622	42	31	.	.	PUNCT
ajlm-622	43	1	the	the	DET
ajlm-622	43	2	mean	mean	ADJ
ajlm-622	43	3	cd4	cd4	PROPN
ajlm-622	43	4	+	+	NOUN
ajlm-622	43	5	counts	count	NOUN
ajlm-622	43	6	of	of	ADP
ajlm-622	43	7	hiv	hiv	PROPN
ajlm-622	43	8	/	/	SYM
ajlm-622	43	9	hbv	hbv	PROPN
ajlm-622	43	10	co	co	VERB
ajlm-622	43	11	-	-	ADJ
ajlm-622	43	12	infected	infected	ADJ
ajlm-622	43	13	patients	patient	NOUN
ajlm-622	43	14	were	be	AUX
ajlm-622	43	15	lower	low	ADJ
ajlm-622	43	16	than	than	ADP
ajlm-622	43	17	patients	patient	NOUN
ajlm-622	43	18	who	who	PRON
ajlm-622	43	19	were	be	AUX
ajlm-622	43	20	only	only	ADV
ajlm-622	43	21	positive	positive	ADJ
ajlm-622	43	22	for	for	ADP
ajlm-622	43	23	hiv	hiv	PROPN
ajlm-622	43	24	;	;	PUNCT
ajlm-622	43	25	this	this	DET
ajlm-622	43	26	difference	difference	NOUN
ajlm-622	43	27	was	be	AUX
ajlm-622	43	28	not	not	PART
ajlm-622	43	29	statistically	statistically	ADV
ajlm-622	43	30	significant	significant	ADJ
ajlm-622	43	31	(	(	PUNCT
ajlm-622	43	32	p	p	X
ajlm-622	43	33	=	=	NOUN
ajlm-622	43	34	0.938	0.938	NUM
ajlm-622	43	35	)	)	PUNCT
ajlm-622	43	36	(	(	PUNCT
ajlm-622	43	37	table	table	NOUN
ajlm-622	43	38	3	3	NUM
ajlm-622	43	39	)	)	PUNCT
ajlm-622	43	40	.	.	PUNCT
ajlm-622	44	1	however	however	ADV
ajlm-622	44	2	,	,	PUNCT
ajlm-622	44	3	the	the	DET
ajlm-622	44	4	mean	mean	ADJ
ajlm-622	44	5	alt	alt	VERB
ajlm-622	44	6	values	value	NOUN
ajlm-622	44	7	for	for	ADP
ajlm-622	44	8	patients	patient	NOUN
ajlm-622	44	9	positive	positive	ADJ
ajlm-622	44	10	for	for	ADP
ajlm-622	44	11	hbsag	hbsag	NOUN
ajlm-622	44	12	were	be	AUX
ajlm-622	44	13	significantly	significantly	ADV
ajlm-622	44	14	higher	high	ADJ
ajlm-622	44	15	than	than	ADP
ajlm-622	44	16	for	for	ADP
ajlm-622	44	17	patients	patient	NOUN
ajlm-622	44	18	negative	negative	ADJ
ajlm-622	44	19	for	for	ADP
ajlm-622	44	20	hbsag	hbsag	NOUN
ajlm-622	44	21	(	(	PUNCT
ajlm-622	44	22	p	p	X
ajlm-622	44	23	=	=	NOUN
ajlm-622	44	24	0.033	0.033	NUM
ajlm-622	44	25	)	)	PUNCT
ajlm-622	44	26	.	.	PUNCT
ajlm-622	45	1	discussion	discussion	NOUN
ajlm-622	45	2	this	this	DET
ajlm-622	45	3	present	present	ADJ
ajlm-622	45	4	study	study	NOUN
ajlm-622	45	5	observed	observe	VERB
ajlm-622	45	6	a	a	DET
ajlm-622	45	7	9.2	9.2	NUM
ajlm-622	45	8	%	%	NOUN
ajlm-622	45	9	sero	sero	NOUN
ajlm-622	45	10	-	-	PUNCT
ajlm-622	45	11	prevalence	prevalence	NOUN
ajlm-622	45	12	of	of	ADP
ajlm-622	45	13	hbsag	hbsag	NOUN
ajlm-622	45	14	among	among	ADP
ajlm-622	45	15	hiv	hiv	PROPN
ajlm-622	45	16	-	-	PUNCT
ajlm-622	45	17	positive	positive	ADJ
ajlm-622	45	18	patients	patient	NOUN
ajlm-622	45	19	attending	attend	VERB
ajlm-622	45	20	the	the	DET
ajlm-622	45	21	hiv	hiv	PROPN
ajlm-622	45	22	treatment	treatment	NOUN
ajlm-622	45	23	clinic	clinic	NOUN
ajlm-622	45	24	at	at	ADP
ajlm-622	45	25	juth	juth	NOUN
ajlm-622	45	26	.	.	PUNCT
ajlm-622	46	1	this	this	PRON
ajlm-622	46	2	is	be	AUX
ajlm-622	46	3	slightly	slightly	ADV
ajlm-622	46	4	lower	low	ADJ
ajlm-622	46	5	than	than	ADP
ajlm-622	46	6	the	the	DET
ajlm-622	46	7	12.5	12.5	NUM
ajlm-622	46	8	%	%	NOUN
ajlm-622	46	9	prevalence	prevalence	NOUN
ajlm-622	46	10	reported	report	VERB
ajlm-622	46	11	from	from	ADP
ajlm-622	46	12	north	north	NOUN
ajlm-622	46	13	-	-	PUNCT
ajlm-622	46	14	western	western	NOUN
ajlm-622	46	15	nigeria	nigeria	PROPN
ajlm-622	46	16	in	in	ADP
ajlm-622	46	17	201315	201315	NUM
ajlm-622	46	18	and	and	CCONJ
ajlm-622	46	19	the	the	DET
ajlm-622	46	20	11.5	11.5	NUM
ajlm-622	46	21	%	%	NOUN
ajlm-622	46	22	observed	observe	VERB
ajlm-622	46	23	in	in	ADP
ajlm-622	46	24	2012	2012	NUM
ajlm-622	46	25	another	another	DET
ajlm-622	46	26	health	health	NOUN
ajlm-622	46	27	facility	facility	NOUN
ajlm-622	46	28	in	in	ADP
ajlm-622	46	29	north	north	NOUN
ajlm-622	46	30	-	-	PUNCT
ajlm-622	46	31	central	central	ADJ
ajlm-622	46	32	nigeria.16	nigeria.16	PROPN
ajlm-622	46	33	however	however	ADV
ajlm-622	46	34	,	,	PUNCT
ajlm-622	46	35	another	another	DET
ajlm-622	46	36	study	study	NOUN
ajlm-622	46	37	conducted	conduct	VERB
ajlm-622	46	38	in	in	ADP
ajlm-622	46	39	southwestern	southwestern	ADJ
ajlm-622	46	40	nigeria	nigeria	PROPN
ajlm-622	46	41	reported	report	VERB
ajlm-622	46	42	a	a	DET
ajlm-622	46	43	much	much	ADV
ajlm-622	46	44	lower	low	ADJ
ajlm-622	46	45	prevalence	prevalence	NOUN
ajlm-622	46	46	of	of	ADP
ajlm-622	46	47	5.7	5.7	NUM
ajlm-622	46	48	%	%	NOUN
ajlm-622	46	49	among	among	ADP
ajlm-622	46	50	hiv	hiv	PROPN
ajlm-622	46	51	-	-	PUNCT
ajlm-622	46	52	positive	positive	ADJ
ajlm-622	46	53	patients	patient	NOUN
ajlm-622	46	54	in	in	ADP
ajlm-622	46	55	2009.17	2009.17	NUM
ajlm-622	46	56	these	these	DET
ajlm-622	46	57	reports	report	NOUN
ajlm-622	46	58	which	which	PRON
ajlm-622	46	59	show	show	VERB
ajlm-622	46	60	differences	difference	NOUN
ajlm-622	46	61	in	in	ADP
ajlm-622	46	62	regional	regional	ADJ
ajlm-622	46	63	prevalence	prevalence	NOUN
ajlm-622	46	64	may	may	AUX
ajlm-622	46	65	point	point	VERB
ajlm-622	46	66	to	to	ADP
ajlm-622	46	67	different	different	ADJ
ajlm-622	46	68	epidemiological	epidemiological	ADJ
ajlm-622	46	69	factors	factor	NOUN
ajlm-622	46	70	at	at	ADP
ajlm-622	46	71	work	work	NOUN
ajlm-622	46	72	in	in	ADP
ajlm-622	46	73	different	different	ADJ
ajlm-622	46	74	parts	part	NOUN
ajlm-622	46	75	of	of	ADP
ajlm-622	46	76	the	the	DET
ajlm-622	46	77	country	country	NOUN
ajlm-622	46	78	and	and	CCONJ
ajlm-622	46	79	reveal	reveal	VERB
ajlm-622	46	80	a	a	DET
ajlm-622	46	81	gap	gap	NOUN
ajlm-622	46	82	in	in	ADP
ajlm-622	46	83	our	our	PRON
ajlm-622	46	84	current	current	ADJ
ajlm-622	46	85	understanding	understanding	NOUN
ajlm-622	46	86	of	of	ADP
ajlm-622	46	87	the	the	DET
ajlm-622	46	88	epidemiology	epidemiology	NOUN
ajlm-622	46	89	of	of	ADP
ajlm-622	46	90	hiv	hiv	PROPN
ajlm-622	46	91	/	/	SYM
ajlm-622	46	92	hbv	hbv	PROPN
ajlm-622	46	93	co	co	NOUN
ajlm-622	46	94	-	-	NOUN
ajlm-622	46	95	infection	infection	NOUN
ajlm-622	46	96	.	.	PUNCT
ajlm-622	47	1	national	national	ADJ
ajlm-622	47	2	surveillance	surveillance	NOUN
ajlm-622	47	3	systems	system	NOUN
ajlm-622	47	4	to	to	PART
ajlm-622	47	5	provide	provide	VERB
ajlm-622	47	6	a	a	DET
ajlm-622	47	7	full	full	ADJ
ajlm-622	47	8	picture	picture	NOUN
ajlm-622	47	9	of	of	ADP
ajlm-622	47	10	the	the	DET
ajlm-622	47	11	co	co	NOUN
ajlm-622	47	12	-	-	ADJ
ajlm-622	47	13	infection	infection	ADJ
ajlm-622	47	14	landscape	landscape	NOUN
ajlm-622	47	15	are	be	AUX
ajlm-622	47	16	urgently	urgently	ADV
ajlm-622	47	17	needed	need	VERB
ajlm-622	47	18	to	to	PART
ajlm-622	47	19	identify	identify	VERB
ajlm-622	47	20	epidemiological	epidemiological	ADJ
ajlm-622	47	21	trends	trend	NOUN
ajlm-622	47	22	over	over	ADP
ajlm-622	47	23	time	time	NOUN
ajlm-622	47	24	to	to	PART
ajlm-622	47	25	make	make	VERB
ajlm-622	47	26	sure	sure	ADJ
ajlm-622	47	27	suitable	suitable	ADJ
ajlm-622	47	28	prevention	prevention	NOUN
ajlm-622	47	29	measures	measure	NOUN
ajlm-622	47	30	are	be	AUX
ajlm-622	47	31	deployed	deploy	VERB
ajlm-622	47	32	.	.	PUNCT
ajlm-622	48	1	our	our	PRON
ajlm-622	48	2	results	result	NOUN
ajlm-622	48	3	agree	agree	VERB
ajlm-622	48	4	with	with	ADP
ajlm-622	48	5	the	the	DET
ajlm-622	48	6	conclusions	conclusion	NOUN
ajlm-622	48	7	of	of	ADP
ajlm-622	48	8	a	a	DET
ajlm-622	48	9	recent	recent	ADJ
ajlm-622	48	10	meta	meta	ADJ
ajlm-622	48	11	-	-	PUNCT
ajlm-622	48	12	analysis	analysis	NOUN
ajlm-622	48	13	by	by	ADP
ajlm-622	48	14	musa	musa	NOUN
ajlm-622	48	15	and	and	CCONJ
ajlm-622	48	16	colleagues6	colleagues6	PROPN
ajlm-622	48	17	that	that	PRON
ajlm-622	48	18	showed	show	VERB
ajlm-622	48	19	that	that	SCONJ
ajlm-622	48	20	in	in	ADP
ajlm-622	48	21	nigeria	nigeria	PROPN
ajlm-622	48	22	,	,	PUNCT
ajlm-622	48	23	there	there	PRON
ajlm-622	48	24	is	be	VERB
ajlm-622	48	25	a	a	DET
ajlm-622	48	26	continued	continue	VERB
ajlm-622	48	27	decline	decline	NOUN
ajlm-622	48	28	in	in	ADP
ajlm-622	48	29	prevalence	prevalence	NOUN
ajlm-622	48	30	of	of	ADP
ajlm-622	48	31	hepatitis	hepatitis	PROPN
ajlm-622	48	32	b	b	NOUN
ajlm-622	48	33	infection	infection	NOUN
ajlm-622	48	34	;	;	PUNCT
ajlm-622	48	35	they	they	PRON
ajlm-622	48	36	estimated	estimate	VERB
ajlm-622	48	37	that	that	SCONJ
ajlm-622	48	38	the	the	DET
ajlm-622	48	39	rate	rate	NOUN
ajlm-622	48	40	of	of	ADP
ajlm-622	48	41	decline	decline	NOUN
ajlm-622	48	42	has	have	AUX
ajlm-622	48	43	been	be	AUX
ajlm-622	48	44	approximately	approximately	ADV
ajlm-622	48	45	0.8	0.8	NUM
ajlm-622	48	46	%	%	NOUN
ajlm-622	48	47	annually	annually	ADV
ajlm-622	48	48	.	.	PUNCT
ajlm-622	49	1	while	while	SCONJ
ajlm-622	49	2	our	our	PRON
ajlm-622	49	3	finding	finding	NOUN
ajlm-622	49	4	provides	provide	VERB
ajlm-622	49	5	significant	significant	ADJ
ajlm-622	49	6	feedback	feedback	NOUN
ajlm-622	49	7	regarding	regard	VERB
ajlm-622	49	8	the	the	DET
ajlm-622	49	9	impact	impact	NOUN
ajlm-622	49	10	of	of	ADP
ajlm-622	49	11	the	the	DET
ajlm-622	49	12	hbv	hbv	NOUN
ajlm-622	49	13	vaccination	vaccination	NOUN
ajlm-622	49	14	programme	programme	NOUN
ajlm-622	49	15	in	in	ADP
ajlm-622	49	16	nigeria	nigeria	PROPN
ajlm-622	49	17	,	,	PUNCT
ajlm-622	49	18	the	the	DET
ajlm-622	49	19	result	result	NOUN
ajlm-622	49	20	remains	remain	VERB
ajlm-622	49	21	higher	high	ADJ
ajlm-622	49	22	than	than	ADP
ajlm-622	49	23	the	the	DET
ajlm-622	49	24	8	8	NUM
ajlm-622	49	25	%	%	NOUN
ajlm-622	49	26	threshold	threshold	NOUN
ajlm-622	49	27	that	that	SCONJ
ajlm-622	49	28	the	the	DET
ajlm-622	49	29	world	world	PROPN
ajlm-622	49	30	health	health	NOUN
ajlm-622	49	31	organization	organization	NOUN
ajlm-622	49	32	considers	consider	VERB
ajlm-622	49	33	endemic	endemic	ADJ
ajlm-622	49	34	among	among	ADP
ajlm-622	49	35	hiv	hiv	PROPN
ajlm-622	49	36	-	-	PUNCT
ajlm-622	49	37	positive	positive	ADJ
ajlm-622	49	38	individuals	individual	NOUN
ajlm-622	49	39	.	.	PUNCT
ajlm-622	50	1	we	we	PRON
ajlm-622	50	2	made	make	VERB
ajlm-622	50	3	an	an	DET
ajlm-622	50	4	observation	observation	NOUN
ajlm-622	50	5	similar	similar	ADJ
ajlm-622	50	6	to	to	ADP
ajlm-622	50	7	other	other	ADJ
ajlm-622	50	8	studies	study	NOUN
ajlm-622	50	9	regarding	regard	VERB
ajlm-622	50	10	men	man	NOUN
ajlm-622	50	11	having	have	VERB
ajlm-622	50	12	higher	high	ADJ
ajlm-622	50	13	rates	rate	NOUN
ajlm-622	50	14	of	of	ADP
ajlm-622	50	15	infection	infection	NOUN
ajlm-622	50	16	than	than	SCONJ
ajlm-622	50	17	women.17,18	women.17,18	VERB
ajlm-622	50	18	the	the	DET
ajlm-622	50	19	report	report	NOUN
ajlm-622	50	20	of	of	ADP
ajlm-622	50	21	a	a	DET
ajlm-622	50	22	recent	recent	ADJ
ajlm-622	50	23	study	study	NOUN
ajlm-622	50	24	by	by	ADP
ajlm-622	50	25	akhtar	akhtar	PROPN
ajlm-622	50	26	et	et	NOUN
ajlm-622	50	27	al.19	al.19	NOUN
ajlm-622	50	28	in	in	ADP
ajlm-622	50	29	a	a	DET
ajlm-622	50	30	tertiary	tertiary	ADJ
ajlm-622	50	31	hospital	hospital	NOUN
ajlm-622	50	32	in	in	ADP
ajlm-622	50	33	malaysia	malaysia	PROPN
ajlm-622	50	34	and	and	CCONJ
ajlm-622	50	35	another	another	DET
ajlm-622	50	36	report	report	NOUN
ajlm-622	50	37	from	from	ADP
ajlm-622	50	38	north	north	NOUN
ajlm-622	50	39	-	-	PUNCT
ajlm-622	50	40	east	east	NOUN
ajlm-622	50	41	nigeria20	nigeria20	NOUN
ajlm-622	50	42	for	for	ADP
ajlm-622	50	43	hbv	hbv	PROPN
ajlm-622	50	44	co	co	NOUN
ajlm-622	50	45	-	-	NOUN
ajlm-622	50	46	infection	infection	NOUN
ajlm-622	50	47	in	in	ADP
ajlm-622	50	48	hiv	hiv	PROPN
ajlm-622	51	1	patients	patient	NOUN
ajlm-622	51	2	agree	agree	VERB
ajlm-622	51	3	with	with	ADP
ajlm-622	51	4	our	our	PRON
ajlm-622	51	5	observation	observation	NOUN
ajlm-622	51	6	of	of	ADP
ajlm-622	51	7	an	an	DET
ajlm-622	51	8	age	age	NOUN
ajlm-622	51	9	-	-	PUNCT
ajlm-622	51	10	specific	specific	ADJ
ajlm-622	51	11	association	association	NOUN
ajlm-622	51	12	in	in	ADP
ajlm-622	51	13	patients	patient	NOUN
ajlm-622	51	14	aged	age	VERB
ajlm-622	51	15	40–49	40–49	NUM
ajlm-622	51	16	years	year	NOUN
ajlm-622	51	17	.	.	PUNCT
ajlm-622	52	1	a	a	DET
ajlm-622	52	2	global	global	ADJ
ajlm-622	52	3	age	age	NOUN
ajlm-622	52	4	-	-	PUNCT
ajlm-622	52	5	specific	specific	ADJ
ajlm-622	52	6	prevalence	prevalence	NOUN
ajlm-622	52	7	,	,	PUNCT
ajlm-622	52	8	which	which	PRON
ajlm-622	52	9	is	be	AUX
ajlm-622	52	10	highest	high	ADJ
ajlm-622	52	11	in	in	ADP
ajlm-622	52	12	sub	sub	ADJ
ajlm-622	52	13	-	-	ADJ
ajlm-622	52	14	saharan	saharan	ADJ
ajlm-622	52	15	africa	africa	PROPN
ajlm-622	52	16	,	,	PUNCT
ajlm-622	52	17	has	have	AUX
ajlm-622	52	18	been	be	AUX
ajlm-622	52	19	reported	report	VERB
ajlm-622	52	20	from	from	ADP
ajlm-622	52	21	a	a	DET
ajlm-622	52	22	systematic	systematic	ADJ
ajlm-622	52	23	review	review	NOUN
ajlm-622	52	24	of	of	ADP
ajlm-622	52	25	data	datum	NOUN
ajlm-622	52	26	on	on	ADP
ajlm-622	52	27	worldwide	worldwide	ADJ
ajlm-622	52	28	prevalence	prevalence	NOUN
ajlm-622	52	29	collected	collect	VERB
ajlm-622	52	30	over	over	ADP
ajlm-622	52	31	a	a	DET
ajlm-622	52	32	27	27	NUM
ajlm-622	52	33	-	-	PUNCT
ajlm-622	52	34	year	year	NOUN
ajlm-622	52	35	period.21	period.21	NOUN
ajlm-622	52	36	the	the	DET
ajlm-622	52	37	association	association	NOUN
ajlm-622	52	38	between	between	ADP
ajlm-622	52	39	increasing	increase	VERB
ajlm-622	52	40	age	age	NOUN
ajlm-622	52	41	and	and	CCONJ
ajlm-622	52	42	being	be	AUX
ajlm-622	52	43	positive	positive	ADJ
ajlm-622	52	44	for	for	ADP
ajlm-622	52	45	hbsag	hbsag	NOUN
ajlm-622	52	46	by	by	ADP
ajlm-622	52	47	several	several	ADJ
ajlm-622	52	48	workers	worker	NOUN
ajlm-622	52	49	reinforces	reinforce	VERB
ajlm-622	52	50	the	the	DET
ajlm-622	52	51	current	current	ADJ
ajlm-622	52	52	paradigm	paradigm	NOUN
ajlm-622	52	53	that	that	PRON
ajlm-622	52	54	the	the	DET
ajlm-622	52	55	epidemiology	epidemiology	NOUN
ajlm-622	52	56	of	of	ADP
ajlm-622	52	57	hbv	hbv	NOUN
ajlm-622	52	58	in	in	ADP
ajlm-622	52	59	nigeria	nigeria	PROPN
ajlm-622	52	60	is	be	AUX
ajlm-622	52	61	primarily	primarily	ADV
ajlm-622	52	62	via	via	ADP
ajlm-622	52	63	horizontal	horizontal	ADJ
ajlm-622	52	64	transmission.22	transmission.22	NOUN
ajlm-622	52	65	in	in	ADP
ajlm-622	52	66	the	the	DET
ajlm-622	52	67	present	present	ADJ
ajlm-622	52	68	study	study	NOUN
ajlm-622	52	69	,	,	PUNCT
ajlm-622	52	70	serum	serum	PROPN
ajlm-622	52	71	alt	alt	PROPN
ajlm-622	52	72	levels	level	NOUN
ajlm-622	52	73	in	in	ADP
ajlm-622	52	74	patients	patient	NOUN
ajlm-622	52	75	who	who	PRON
ajlm-622	52	76	were	be	AUX
ajlm-622	52	77	positive	positive	ADJ
ajlm-622	52	78	for	for	ADP
ajlm-622	52	79	hbsag	hbsag	NOUN
ajlm-622	52	80	were	be	AUX
ajlm-622	52	81	significantly	significantly	ADV
ajlm-622	52	82	higher	high	ADJ
ajlm-622	52	83	than	than	ADP
ajlm-622	52	84	alt	alt	VERB
ajlm-622	52	85	levels	level	NOUN
ajlm-622	52	86	in	in	ADP
ajlm-622	52	87	patients	patient	NOUN
ajlm-622	52	88	who	who	PRON
ajlm-622	52	89	were	be	AUX
ajlm-622	52	90	hbsag	hbsag	ADJ
ajlm-622	52	91	-	-	PUNCT
ajlm-622	52	92	negative	negative	ADJ
ajlm-622	52	93	,	,	PUNCT
ajlm-622	52	94	which	which	PRON
ajlm-622	52	95	is	be	AUX
ajlm-622	52	96	a	a	DET
ajlm-622	52	97	comparable	comparable	ADJ
ajlm-622	52	98	observation	observation	NOUN
ajlm-622	52	99	to	to	ADP
ajlm-622	52	100	that	that	PRON
ajlm-622	52	101	made	make	VERB
ajlm-622	52	102	by	by	ADP
ajlm-622	52	103	otegbayo	otegbayo	PROPN
ajlm-622	52	104	et	et	PROPN
ajlm-622	52	105	al.23	al.23	PROPN
ajlm-622	52	106	it	it	PRON
ajlm-622	52	107	is	be	AUX
ajlm-622	52	108	possible	possible	ADJ
ajlm-622	52	109	that	that	SCONJ
ajlm-622	52	110	the	the	DET
ajlm-622	52	111	patients	patient	NOUN
ajlm-622	52	112	in	in	ADP
ajlm-622	52	113	our	our	PRON
ajlm-622	52	114	study	study	NOUN
ajlm-622	52	115	population	population	NOUN
ajlm-622	52	116	were	be	AUX
ajlm-622	52	117	in	in	ADP
ajlm-622	52	118	the	the	DET
ajlm-622	52	119	late	late	ADJ
ajlm-622	52	120	reactivation	reactivation	NOUN
ajlm-622	52	121	phase	phase	NOUN
ajlm-622	52	122	where	where	SCONJ
ajlm-622	52	123	high	high	ADJ
ajlm-622	52	124	serum	serum	NOUN
ajlm-622	52	125	alt	alt	PROPN
ajlm-622	52	126	levels	level	NOUN
ajlm-622	52	127	accompany	accompany	VERB
ajlm-622	52	128	progressive	progressive	ADJ
ajlm-622	52	129	liver	liver	NOUN
ajlm-622	52	130	damage.24	damage.24	NOUN
ajlm-622	52	131	there	there	PRON
ajlm-622	52	132	is	be	VERB
ajlm-622	52	133	a	a	DET
ajlm-622	52	134	growing	grow	VERB
ajlm-622	52	135	interest	interest	NOUN
ajlm-622	52	136	in	in	ADP
ajlm-622	52	137	understanding	understand	VERB
ajlm-622	52	138	serum	serum	VERB
ajlm-622	52	139	hbsag	hbsag	ADJ
ajlm-622	52	140	levels	level	NOUN
ajlm-622	52	141	across	across	ADP
ajlm-622	52	142	the	the	DET
ajlm-622	52	143	different	different	ADJ
ajlm-622	52	144	phases	phase	NOUN
ajlm-622	52	145	of	of	ADP
ajlm-622	52	146	hbv	hbv	NOUN
ajlm-622	52	147	infection.25	infection.25	PROPN
ajlm-622	52	148	however	however	ADV
ajlm-622	52	149	,	,	PUNCT
ajlm-622	52	150	our	our	PRON
ajlm-622	52	151	inability	inability	NOUN
ajlm-622	52	152	to	to	PART
ajlm-622	52	153	quantify	quantify	VERB
ajlm-622	52	154	hbsag	hbsag	ADJ
ajlm-622	52	155	titers	titer	NOUN
ajlm-622	52	156	and	and	CCONJ
ajlm-622	52	157	ascertain	ascertain	VERB
ajlm-622	52	158	the	the	DET
ajlm-622	52	159	different	different	ADJ
ajlm-622	52	160	phases	phase	NOUN
ajlm-622	52	161	of	of	ADP
ajlm-622	52	162	infection	infection	NOUN
ajlm-622	52	163	are	be	AUX
ajlm-622	52	164	limitations	limitation	NOUN
ajlm-622	52	165	of	of	ADP
ajlm-622	52	166	our	our	PRON
ajlm-622	52	167	study	study	NOUN
ajlm-622	52	168	.	.	PUNCT
ajlm-622	53	1	although	although	SCONJ
ajlm-622	53	2	two	two	NUM
ajlm-622	53	3	studies	study	NOUN
ajlm-622	53	4	documenting	document	VERB
ajlm-622	53	5	the	the	DET
ajlm-622	53	6	natural	natural	ADJ
ajlm-622	53	7	history	history	NOUN
ajlm-622	53	8	of	of	ADP
ajlm-622	53	9	the	the	DET
ajlm-622	53	10	infection	infection	NOUN
ajlm-622	53	11	in	in	ADP
ajlm-622	53	12	asian	asian	ADJ
ajlm-622	53	13	and	and	CCONJ
ajlm-622	53	14	european	european	ADJ
ajlm-622	53	15	cohorts	cohort	NOUN
ajlm-622	53	16	reported	report	VERB
ajlm-622	53	17	no	no	DET
ajlm-622	53	18	significant	significant	ADJ
ajlm-622	53	19	association	association	NOUN
ajlm-622	53	20	between	between	ADP
ajlm-622	53	21	alt	alt	PROPN
ajlm-622	53	22	activity	activity	NOUN
ajlm-622	53	23	and	and	CCONJ
ajlm-622	53	24	serum	serum	VERB
ajlm-622	53	25	hbsag	hbsag	PROPN
ajlm-622	53	26	titers,26,27	titers,26,27	PROPN
ajlm-622	53	27	an	an	DET
ajlm-622	53	28	african	african	ADJ
ajlm-622	53	29	perspective	perspective	NOUN
ajlm-622	53	30	for	for	ADP
ajlm-622	53	31	the	the	DET
ajlm-622	53	32	different	different	ADJ
ajlm-622	53	33	phases	phase	NOUN
ajlm-622	53	34	may	may	AUX
ajlm-622	53	35	reveal	reveal	VERB
ajlm-622	53	36	a	a	DET
ajlm-622	53	37	different	different	ADJ
ajlm-622	53	38	picture	picture	NOUN
ajlm-622	53	39	in	in	ADP
ajlm-622	53	40	the	the	DET
ajlm-622	53	41	course	course	NOUN
ajlm-622	53	42	of	of	ADP
ajlm-622	53	43	infection	infection	NOUN
ajlm-622	53	44	.	.	PUNCT
ajlm-622	54	1	conclusion	conclusion	NOUN
ajlm-622	54	2	despite	despite	SCONJ
ajlm-622	54	3	the	the	DET
ajlm-622	54	4	overall	overall	ADJ
ajlm-622	54	5	decline	decline	NOUN
ajlm-622	54	6	in	in	ADP
ajlm-622	54	7	hbv	hbv	NOUN
ajlm-622	54	8	prevalence	prevalence	NOUN
ajlm-622	54	9	,	,	PUNCT
ajlm-622	54	10	it	it	PRON
ajlm-622	54	11	remains	remain	VERB
ajlm-622	54	12	endemic	endemic	ADJ
ajlm-622	54	13	in	in	ADP
ajlm-622	54	14	hiv	hiv	PROPN
ajlm-622	54	15	-	-	PUNCT
ajlm-622	54	16	positive	positive	ADJ
ajlm-622	54	17	populations	population	NOUN
ajlm-622	54	18	and	and	CCONJ
ajlm-622	54	19	requires	require	VERB
ajlm-622	54	20	effective	effective	ADJ
ajlm-622	54	21	surveillance	surveillance	NOUN
ajlm-622	54	22	to	to	PART
ajlm-622	54	23	fully	fully	ADV
ajlm-622	54	24	understand	understand	VERB
ajlm-622	54	25	the	the	DET
ajlm-622	54	26	epidemiology	epidemiology	NOUN
ajlm-622	54	27	of	of	ADP
ajlm-622	54	28	hiv	hiv	PROPN
ajlm-622	54	29	/	/	SYM
ajlm-622	54	30	hbv	hbv	PROPN
ajlm-622	54	31	co	co	NOUN
ajlm-622	54	32	-	-	NOUN
ajlm-622	54	33	infection	infection	NOUN
ajlm-622	54	34	in	in	ADP
ajlm-622	54	35	nigeria	nigeria	PROPN
ajlm-622	54	36	.	.	PUNCT
ajlm-622	55	1	increased	increase	VERB
ajlm-622	55	2	uptake	uptake	NOUN
ajlm-622	55	3	of	of	ADP
ajlm-622	55	4	a	a	DET
ajlm-622	55	5	vaccination	vaccination	NOUN
ajlm-622	55	6	programme	programme	NOUN
ajlm-622	55	7	among	among	ADP
ajlm-622	55	8	hiv	hiv	PROPN
ajlm-622	55	9	-	-	PUNCT
ajlm-622	55	10	positive	positive	ADJ
ajlm-622	55	11	patients	patient	NOUN
ajlm-622	55	12	who	who	PRON
ajlm-622	55	13	are	be	AUX
ajlm-622	55	14	susceptible	susceptible	ADJ
ajlm-622	55	15	to	to	ADP
ajlm-622	55	16	hbv	hbv	NOUN
ajlm-622	55	17	infection	infection	NOUN
ajlm-622	55	18	,	,	PUNCT
ajlm-622	55	19	along	along	ADP
ajlm-622	55	20	with	with	ADP
ajlm-622	55	21	the	the	DET
ajlm-622	55	22	identification	identification	NOUN
ajlm-622	55	23	of	of	ADP
ajlm-622	55	24	patients	patient	NOUN
ajlm-622	55	25	with	with	ADP
ajlm-622	55	26	hbv	hbv	NOUN
ajlm-622	55	27	infection	infection	NOUN
ajlm-622	55	28	for	for	ADP
ajlm-622	55	29	treatment	treatment	NOUN
ajlm-622	55	30	,	,	PUNCT
ajlm-622	55	31	are	be	AUX
ajlm-622	55	32	critical	critical	ADJ
ajlm-622	55	33	strategies	strategy	NOUN
ajlm-622	55	34	in	in	ADP
ajlm-622	55	35	prevention	prevention	NOUN
ajlm-622	55	36	and	and	CCONJ
ajlm-622	55	37	control	control	NOUN
ajlm-622	55	38	activities	activity	NOUN
ajlm-622	55	39	.	.	PUNCT
ajlm-622	56	1	acknowledgements	acknowledgement	NOUN
ajlm-622	56	2	we	we	PRON
ajlm-622	56	3	are	be	AUX
ajlm-622	56	4	grateful	grateful	ADJ
ajlm-622	56	5	to	to	ADP
ajlm-622	56	6	the	the	DET
ajlm-622	56	7	management	management	NOUN
ajlm-622	56	8	of	of	ADP
ajlm-622	56	9	the	the	DET
ajlm-622	56	10	juth	juth	ADJ
ajlm-622	56	11	infectious	infectious	ADJ
ajlm-622	56	12	diseases	disease	NOUN
ajlm-622	56	13	unit	unit	NOUN
ajlm-622	56	14	for	for	ADP
ajlm-622	56	15	their	their	PRON
ajlm-622	56	16	support	support	NOUN
ajlm-622	56	17	and	and	CCONJ
ajlm-622	56	18	also	also	ADV
ajlm-622	56	19	to	to	ADP
ajlm-622	56	20	the	the	DET
ajlm-622	56	21	entire	entire	ADJ
ajlm-622	56	22	staff	staff	NOUN
ajlm-622	56	23	of	of	ADP
ajlm-622	56	24	the	the	DET
ajlm-622	56	25	centre	centre	NOUN
ajlm-622	56	26	for	for	ADP
ajlm-622	56	27	their	their	PRON
ajlm-622	56	28	cooperation	cooperation	NOUN
ajlm-622	56	29	and	and	CCONJ
ajlm-622	56	30	technical	technical	ADJ
ajlm-622	56	31	contributions	contribution	NOUN
ajlm-622	56	32	to	to	ADP
ajlm-622	56	33	this	this	DET
ajlm-622	56	34	study	study	NOUN
ajlm-622	56	35	.	.	PUNCT
ajlm-622	57	1	competing	compete	VERB
ajlm-622	57	2	interests	interest	NOUN
ajlm-622	57	3	the	the	DET
ajlm-622	57	4	authors	author	NOUN
ajlm-622	57	5	declare	declare	VERB
ajlm-622	57	6	that	that	SCONJ
ajlm-622	57	7	they	they	PRON
ajlm-622	57	8	have	have	VERB
ajlm-622	57	9	no	no	DET
ajlm-622	57	10	financial	financial	ADJ
ajlm-622	57	11	or	or	CCONJ
ajlm-622	57	12	personal	personal	ADJ
ajlm-622	57	13	relationships	relationship	NOUN
ajlm-622	57	14	that	that	PRON
ajlm-622	57	15	may	may	AUX
ajlm-622	57	16	have	have	AUX
ajlm-622	57	17	inappropriately	inappropriately	ADV
ajlm-622	57	18	influenced	influence	VERB
ajlm-622	57	19	them	they	PRON
ajlm-622	57	20	in	in	ADP
ajlm-622	57	21	writing	write	VERB
ajlm-622	57	22	this	this	DET
ajlm-622	57	23	article	article	NOUN
ajlm-622	57	24	.	.	PUNCT
ajlm-622	58	1	authors	author	NOUN
ajlm-622	58	2	’	'	PUNCT
ajlm-622	58	3	contributions	contribution	NOUN
ajlm-622	58	4	this	this	DET
ajlm-622	58	5	work	work	NOUN
ajlm-622	58	6	was	be	AUX
ajlm-622	58	7	carried	carry	VERB
ajlm-622	58	8	out	out	ADP
ajlm-622	58	9	in	in	ADP
ajlm-622	58	10	collaboration	collaboration	NOUN
ajlm-622	58	11	between	between	ADP
ajlm-622	58	12	all	all	DET
ajlm-622	58	13	authors	author	NOUN
ajlm-622	58	14	.	.	PUNCT
ajlm-622	59	1	author	author	NOUN
ajlm-622	59	2	t.m.a	t.m.a	PROPN
ajlm-622	59	3	.	.	PUNCT
ajlm-622	59	4	performed	perform	VERB
ajlm-622	59	5	data	datum	NOUN
ajlm-622	59	6	analysis	analysis	NOUN
ajlm-622	59	7	and	and	CCONJ
ajlm-622	59	8	result	result	NOUN
ajlm-622	59	9	interpretation	interpretation	NOUN
ajlm-622	59	10	,	,	PUNCT
ajlm-622	59	11	prepared	prepare	VERB
ajlm-622	59	12	the	the	DET
ajlm-622	59	13	tables	table	NOUN
ajlm-622	59	14	,	,	PUNCT
ajlm-622	59	15	wrote	write	VERB
ajlm-622	59	16	the	the	DET
ajlm-622	59	17	final	final	ADJ
ajlm-622	59	18	manuscript	manuscript	NOUN
ajlm-622	59	19	and	and	CCONJ
ajlm-622	59	20	reviewed	review	VERB
ajlm-622	59	21	the	the	DET
ajlm-622	59	22	final	final	ADJ
ajlm-622	59	23	draft	draft	NOUN
ajlm-622	59	24	.	.	PUNCT
ajlm-622	60	1	c.o.r	c.o.r	PROPN
ajlm-622	60	2	.	.	PROPN
ajlm-622	60	3	&	&	CCONJ
ajlm-622	60	4	a.o.j	a.o.j	PROPN
ajlm-622	60	5	.	.	PUNCT
ajlm-622	60	6	designed	design	VERB
ajlm-622	60	7	and	and	CCONJ
ajlm-622	60	8	performed	perform	VERB
ajlm-622	60	9	the	the	DET
ajlm-622	60	10	experiments	experiment	NOUN
ajlm-622	60	11	,	,	PUNCT
ajlm-622	60	12	and	and	CCONJ
ajlm-622	60	13	wrote	write	VERB
ajlm-622	60	14	and	and	CCONJ
ajlm-622	60	15	reviewed	review	VERB
ajlm-622	60	16	manuscript	manuscript	NOUN
ajlm-622	60	17	.	.	PUNCT
ajlm-622	61	1	j.a.a.-o	j.a.a.-o	NOUN
ajlm-622	61	2	.	.	PUNCT
ajlm-622	62	1	conceptualised	conceptualise	VERB
ajlm-622	62	2	the	the	DET
ajlm-622	62	3	experiment	experiment	NOUN
ajlm-622	62	4	protocol	protocol	NOUN
ajlm-622	62	5	,	,	PUNCT
ajlm-622	62	6	supervised	supervise	VERB
ajlm-622	62	7	the	the	DET
ajlm-622	62	8	experiments	experiment	NOUN
ajlm-622	62	9	and	and	CCONJ
ajlm-622	62	10	reviewed	review	VERB
ajlm-622	62	11	the	the	DET
ajlm-622	62	12	final	final	ADJ
ajlm-622	62	13	draft	draft	NOUN
ajlm-622	62	14	of	of	ADP
ajlm-622	62	15	the	the	DET
ajlm-622	62	16	manuscript	manuscript	NOUN
ajlm-622	62	17	.	.	PUNCT
ajlm-622	63	1	j.n.o	j.n.o	PROPN
ajlm-622	63	2	.	.	PROPN
ajlm-622	63	3	and	and	CCONJ
ajlm-622	63	4	o.j.o	o.j.o	PROPN
ajlm-622	63	5	.	.	PROPN
ajlm-622	63	6	reviewed	review	VERB
ajlm-622	63	7	the	the	DET
ajlm-622	63	8	manuscript	manuscript	NOUN
ajlm-622	63	9	and	and	CCONJ
ajlm-622	63	10	made	make	VERB
ajlm-622	63	11	corrections	correction	NOUN
ajlm-622	63	12	to	to	PART
ajlm-622	63	13	manuscript	manuscript	VERB
ajlm-622	63	14	.	.	PUNCT
ajlm-622	64	1	all	all	DET
ajlm-622	64	2	authors	author	NOUN
ajlm-622	64	3	read	read	VERB
ajlm-622	64	4	and	and	CCONJ
ajlm-622	64	5	approved	approve	VERB
ajlm-622	64	6	the	the	DET
ajlm-622	64	7	final	final	ADJ
ajlm-622	64	8	manuscript	manuscript	NOUN
ajlm-622	64	9	.	.	PUNCT
ajlm-622	65	1	source	source	NOUN
ajlm-622	65	2	of	of	ADP
ajlm-622	65	3	support	support	NOUN
ajlm-622	65	4	none	none	NOUN
ajlm-622	65	5	.	.	PUNCT
ajlm-622	66	1	references	reference	NOUN
ajlm-622	66	2	hwang	hwang	PROPN
ajlm-622	66	3	ew	ew	PROPN
ajlm-622	66	4	,	,	PUNCT
ajlm-622	66	5	cheung	cheung	PROPN
ajlm-622	66	6	r.	r.	PROPN
ajlm-622	66	7	global	global	PROPN
ajlm-622	66	8	epidemiology	epidemiology	PROPN
ajlm-622	66	9	of	of	ADP
ajlm-622	66	10	hepatitis	hepatitis	PROPN
ajlm-622	66	11	b	b	PROPN
ajlm-622	66	12	virus	virus	NOUN
ajlm-622	66	13	(	(	PUNCT
ajlm-622	66	14	hbv	hbv	NOUN
ajlm-622	66	15	)	)	PUNCT
ajlm-622	66	16	infection	infection	NOUN
ajlm-622	66	17	.	.	PUNCT
ajlm-622	67	1	n	n	PRON
ajlm-622	67	2	am	be	AUX
ajlm-622	67	3	j	j	PROPN
ajlm-622	67	4	med	med	PROPN
ajlm-622	67	5	sci	sci	PROPN
ajlm-622	67	6	.	.	PUNCT
ajlm-622	68	1	2011;4(1):7–13	2011;4(1):7–13	NUM
ajlm-622	68	2	.	.	PUNCT
ajlm-622	68	3	https://doi.org/10.7156/v4i1p007	https://doi.org/10.7156/v4i1p007	PUNCT
ajlm-622	68	4	kiire	kiire	NOUN
ajlm-622	68	5	cf	cf	NOUN
ajlm-622	68	6	.	.	PUNCT
ajlm-622	69	1	the	the	DET
ajlm-622	69	2	epidemiology	epidemiology	NOUN
ajlm-622	69	3	and	and	CCONJ
ajlm-622	69	4	prophylaxis	prophylaxis	NOUN
ajlm-622	69	5	of	of	ADP
ajlm-622	69	6	hepatitis	hepatitis	PROPN
ajlm-622	69	7	b	b	PROPN
ajlm-622	69	8	in	in	ADP
ajlm-622	69	9	sub	sub	ADJ
ajlm-622	69	10	-	-	ADJ
ajlm-622	69	11	saharan	saharan	ADJ
ajlm-622	69	12	africa	africa	PROPN
ajlm-622	69	13	:	:	PUNCT
ajlm-622	69	14	a	a	DET
ajlm-622	69	15	view	view	NOUN
ajlm-622	69	16	from	from	ADP
ajlm-622	69	17	tropical	tropical	ADJ
ajlm-622	69	18	and	and	CCONJ
ajlm-622	69	19	subtropical	subtropical	ADJ
ajlm-622	69	20	africa	africa	PROPN
ajlm-622	69	21	.	.	PUNCT
ajlm-622	70	1	gut	gut	VERB
ajlm-622	70	2	.	.	PUNCT
ajlm-622	71	1	1996;38(suppl	1996;38(suppl	PROPN
ajlm-622	71	2	2):s5	2):s5	NUM
ajlm-622	71	3	–	–	PUNCT
ajlm-622	71	4	s12	s12	NOUN
ajlm-622	71	5	.	.	PUNCT
ajlm-622	72	1	https://doi.org/10.1136/gut.38.suppl_2.s5	https://doi.org/10.1136/gut.38.suppl_2.s5	PROPN
ajlm-622	72	2	hoffmann	hoffmann	PROPN
ajlm-622	72	3	cj	cj	PROPN
ajlm-622	72	4	,	,	PUNCT
ajlm-622	72	5	thio	thio	NOUN
ajlm-622	72	6	cl	cl	NOUN
ajlm-622	72	7	.	.	PUNCT
ajlm-622	73	1	clinical	clinical	ADJ
ajlm-622	73	2	implications	implication	NOUN
ajlm-622	73	3	of	of	ADP
ajlm-622	73	4	hiv	hiv	PROPN
ajlm-622	73	5	and	and	CCONJ
ajlm-622	73	6	hepatitis	hepatitis	PROPN
ajlm-622	73	7	b	b	PROPN
ajlm-622	73	8	co	co	NOUN
ajlm-622	73	9	-	-	NOUN
ajlm-622	73	10	infection	infection	NOUN
ajlm-622	73	11	in	in	ADP
ajlm-622	73	12	asia	asia	PROPN
ajlm-622	73	13	and	and	CCONJ
ajlm-622	73	14	africa	africa	PROPN
ajlm-622	73	15	.	.	PUNCT
ajlm-622	74	1	lancet	lancet	PROPN
ajlm-622	74	2	infect	infect	PROPN
ajlm-622	74	3	dis	dis	PROPN
ajlm-622	74	4	.	.	PUNCT
ajlm-622	75	1	2007;7:402–409	2007;7:402–409	X
ajlm-622	75	2	.	.	PUNCT
ajlm-622	75	3	https://doi.org/10.1016/s1473-3099(07)70135-4	https://doi.org/10.1016/s1473-3099(07)70135-4	PROPN
ajlm-622	75	4	bosch	bosch	PROPN
ajlm-622	75	5	fx	fx	PROPN
ajlm-622	75	6	,	,	PUNCT
ajlm-622	75	7	ribes	ribes	PROPN
ajlm-622	75	8	j	j	PROPN
ajlm-622	75	9	,	,	PUNCT
ajlm-622	75	10	diaz	diaz	PROPN
ajlm-622	75	11	m	m	PROPN
ajlm-622	75	12	,	,	PUNCT
ajlm-622	75	13	cléries	clérie	NOUN
ajlm-622	75	14	r.	r.	PROPN
ajlm-622	75	15	primary	primary	ADJ
ajlm-622	75	16	liver	liver	NOUN
ajlm-622	75	17	cancer	cancer	NOUN
ajlm-622	75	18	:	:	PUNCT
ajlm-622	75	19	world	world	NOUN
ajlm-622	75	20	-	-	PUNCT
ajlm-622	75	21	wide	wide	ADJ
ajlm-622	75	22	incidence	incidence	NOUN
ajlm-622	75	23	and	and	CCONJ
ajlm-622	75	24	trends	trend	NOUN
ajlm-622	75	25	.	.	PUNCT
ajlm-622	76	1	gastroenterol	gastroenterol	NOUN
ajlm-622	76	2	.	.	PUNCT
ajlm-622	77	1	2004;127(5	2004;127(5	NUM
ajlm-622	77	2	suppl	suppl	ADJ
ajlm-622	77	3	1):s5	1):s5	NUM
ajlm-622	77	4	–	–	PUNCT
ajlm-622	77	5	s16	s16	NOUN
ajlm-622	77	6	.	.	PUNCT
ajlm-622	78	1	https://doi.org/10.1053/j.gastro.2004.09.011	https://doi.org/10.1053/j.gastro.2004.09.011	PROPN
ajlm-622	78	2	sharma	sharma	PROPN
ajlm-622	78	3	skj	skj	PROPN
ajlm-622	78	4	,	,	PUNCT
ajlm-622	78	5	saini	saini	PROPN
ajlm-622	78	6	n	n	CCONJ
ajlm-622	78	7	,	,	PUNCT
ajlm-622	78	8	chwla	chwla	PROPN
ajlm-622	78	9	y.	y.	PROPN
ajlm-622	78	10	hepatitis	hepatitis	PROPN
ajlm-622	78	11	b.	b.	PROPN
ajlm-622	78	12	virus	virus	PROPN
ajlm-622	78	13	:	:	PUNCT
ajlm-622	78	14	in	in	ADP
ajlm-622	78	15	active	active	ADJ
ajlm-622	78	16	.	.	PUNCT
ajlm-622	79	1	curr	curr	PROPN
ajlm-622	79	2	immunol	immunol	PROPN
ajlm-622	79	3	j.	j.	PROPN
ajlm-622	79	4	2005;2:82	2005;2:82	PROPN
ajlm-622	79	5	.	.	PUNCT
ajlm-622	80	1	musa	musa	PROPN
ajlm-622	80	2	bm	bm	PROPN
ajlm-622	80	3	,	,	PUNCT
ajlm-622	80	4	bussell	bussell	VERB
ajlm-622	80	5	s	s	NOUN
ajlm-622	80	6	,	,	PUNCT
ajlm-622	80	7	borodo	borodo	PROPN
ajlm-622	80	8	mm	mm	PROPN
ajlm-622	80	9	,	,	PUNCT
ajlm-622	80	10	samaila	samaila	PROPN
ajlm-622	80	11	aa	aa	PROPN
ajlm-622	80	12	,	,	PUNCT
ajlm-622	80	13	femi	femi	PROPN
ajlm-622	80	14	ol	ol	PROPN
ajlm-622	80	15	.	.	PUNCT
ajlm-622	81	1	prevalence	prevalence	NOUN
ajlm-622	81	2	of	of	ADP
ajlm-622	81	3	hepatitis	hepatitis	PROPN
ajlm-622	81	4	b	b	PROPN
ajlm-622	81	5	virus	virus	NOUN
ajlm-622	81	6	infection	infection	NOUN
ajlm-622	81	7	in	in	ADP
ajlm-622	81	8	nigeria	nigeria	PROPN
ajlm-622	81	9	,	,	PUNCT
ajlm-622	81	10	2000–2013	2000–2013	NUM
ajlm-622	81	11	:	:	PUNCT
ajlm-622	81	12	a	a	DET
ajlm-622	81	13	systematic	systematic	ADJ
ajlm-622	81	14	review	review	NOUN
ajlm-622	81	15	and	and	CCONJ
ajlm-622	81	16	meta	meta	ADJ
ajlm-622	81	17	-	-	PUNCT
ajlm-622	81	18	analysis	analysis	NOUN
ajlm-622	81	19	.	.	PUNCT
ajlm-622	82	1	niger	niger	PROPN
ajlm-622	82	2	j	j	PROPN
ajlm-622	82	3	clin	clin	PROPN
ajlm-622	82	4	pract	pract	PROPN
ajlm-622	82	5	.	.	PUNCT
ajlm-622	83	1	2015;18(2):163–172	2015;18(2):163–172	X
ajlm-622	83	2	.	.	PUNCT
ajlm-622	84	1	https://doi.org/10.4103/1119-3077.151035	https://doi.org/10.4103/1119-3077.151035	PROPN
ajlm-622	84	2	lok	lok	PROPN
ajlm-622	84	3	a.	a.	PROPN
ajlm-622	84	4	hepatitis	hepatitis	PROPN
ajlm-622	84	5	b	b	PROPN
ajlm-622	84	6	virus	virus	NOUN
ajlm-622	84	7	infection	infection	NOUN
ajlm-622	84	8	and	and	CCONJ
ajlm-622	84	9	liver	liver	NOUN
ajlm-622	84	10	transplantation	transplantation	NOUN
ajlm-622	84	11	.	.	PUNCT
ajlm-622	85	1	j	j	PROPN
ajlm-622	85	2	virol	virol	NOUN
ajlm-622	85	3	.	.	PUNCT
ajlm-622	86	1	2005;24:112–114	2005;24:112–114	X
ajlm-622	86	2	.	.	PUNCT
ajlm-622	86	3	alter	alter	PROPN
ajlm-622	86	4	mj	mj	PROPN
ajlm-622	86	5	.	.	PROPN
ajlm-622	86	6	epidemiology	epidemiology	NOUN
ajlm-622	86	7	of	of	ADP
ajlm-622	86	8	viral	viral	ADJ
ajlm-622	86	9	hepatitis	hepatitis	NOUN
ajlm-622	86	10	and	and	CCONJ
ajlm-622	86	11	hiv	hiv	PROPN
ajlm-622	86	12	co	co	NOUN
ajlm-622	86	13	-	-	NOUN
ajlm-622	86	14	infection	infection	NOUN
ajlm-622	86	15	.	.	PUNCT
ajlm-622	87	1	j	j	PROPN
ajlm-622	87	2	hepatol	hepatol	ADJ
ajlm-622	87	3	.	.	PUNCT
ajlm-622	88	1	2006;44	2006;44	NUM
ajlm-622	88	2	:	:	PUNCT
ajlm-622	88	3	s6	s6	PROPN
ajlm-622	88	4	–	–	PUNCT
ajlm-622	88	5	s9	s9	NOUN
ajlm-622	88	6	.	.	PUNCT
ajlm-622	89	1	https://doi.org/10.1016/j.jhep.2005.11.004	https://doi.org/10.1016/j.jhep.2005.11.004	PROPN
ajlm-622	89	2	ockenga	ockenga	PROPN
ajlm-622	89	3	j	j	PROPN
ajlm-622	89	4	,	,	PUNCT
ajlm-622	89	5	tillmann	tillmann	PROPN
ajlm-622	89	6	hl	hl	NOUN
ajlm-622	89	7	,	,	PUNCT
ajlm-622	89	8	trautwein	trautwein	ADV
ajlm-622	89	9	c	c	X
ajlm-622	89	10	,	,	PUNCT
ajlm-622	89	11	stoll	stoll	PROPN
ajlm-622	89	12	m	m	PROPN
ajlm-622	89	13	,	,	PUNCT
ajlm-622	89	14	manns	manns	PROPN
ajlm-622	89	15	mp	mp	PROPN
ajlm-622	89	16	,	,	PUNCT
ajlm-622	89	17	schmidt	schmidt	PROPN
ajlm-622	89	18	re	re	PROPN
ajlm-622	89	19	.	.	PUNCT
ajlm-622	90	1	hepatitis	hepatitis	PROPN
ajlm-622	90	2	b	b	PROPN
ajlm-622	90	3	and	and	CCONJ
ajlm-622	90	4	c	c	PROPN
ajlm-622	90	5	in	in	ADP
ajlm-622	90	6	hiv	hiv	PROPN
ajlm-622	90	7	-	-	PUNCT
ajlm-622	90	8	infected	infect	VERB
ajlm-622	90	9	patients	patient	NOUN
ajlm-622	90	10	.	.	PUNCT
ajlm-622	91	1	prevalence	prevalence	NOUN
ajlm-622	91	2	and	and	CCONJ
ajlm-622	91	3	prognostic	prognostic	ADJ
ajlm-622	91	4	value	value	NOUN
ajlm-622	91	5	.	.	PUNCT
ajlm-622	92	1	j	j	PROPN
ajlm-622	92	2	hepatol	hepatol	ADJ
ajlm-622	92	3	.	.	PUNCT
ajlm-622	93	1	1997;27:18–24	1997;27:18–24	NUM
ajlm-622	93	2	.	.	PUNCT
ajlm-622	94	1	https://doi.org/10.1016/s0168-8278(97)80274-7	https://doi.org/10.1016/s0168-8278(97)80274-7	PROPN
ajlm-622	94	2	pouti	pouti	PROPN
ajlm-622	94	3	m	m	PROPN
ajlm-622	94	4	,	,	PUNCT
ajlm-622	94	5	torti	torti	PROPN
ajlm-622	94	6	c	c	PROPN
ajlm-622	94	7	,	,	PUNCT
ajlm-622	94	8	bruno	bruno	PROPN
ajlm-622	94	9	r	r	PROPN
ajlm-622	94	10	,	,	PUNCT
ajlm-622	94	11	filice	filice	NOUN
ajlm-622	94	12	g	g	NOUN
ajlm-622	94	13	,	,	PUNCT
ajlm-622	94	14	carosi	carosi	NOUN
ajlm-622	94	15	g.	g.	PROPN
ajlm-622	94	16	natural	natural	ADJ
ajlm-622	94	17	history	history	NOUN
ajlm-622	94	18	of	of	ADP
ajlm-622	94	19	chronic	chronic	ADJ
ajlm-622	94	20	hepatitis	hepatitis	PROPN
ajlm-622	94	21	b	b	PROPN
ajlm-622	94	22	in	in	ADP
ajlm-622	94	23	co	co	ADJ
ajlm-622	94	24	-	-	ADJ
ajlm-622	94	25	infected	infected	ADJ
ajlm-622	94	26	patients	patient	NOUN
ajlm-622	94	27	.	.	PUNCT
ajlm-622	95	1	j	j	PROPN
ajlm-622	95	2	hepatol	hepatol	ADJ
ajlm-622	95	3	.	.	PUNCT
ajlm-622	96	1	2006;44	2006;44	NOUN
ajlm-622	96	2	:	:	PUNCT
ajlm-622	96	3	s65	s65	PROPN
ajlm-622	96	4	–	–	PUNCT
ajlm-622	96	5	s70	s70	NOUN
ajlm-622	96	6	.	.	PUNCT
ajlm-622	97	1	https://doi.org/10.1016/j.jhep.2005.11.015	https://doi.org/10.1016/j.jhep.2005.11.015	X
ajlm-622	97	2	sulkowski	sulkowski	PROPN
ajlm-622	97	3	ms	ms	PROPN
ajlm-622	97	4	,	,	PUNCT
ajlm-622	97	5	thomas	thomas	PROPN
ajlm-622	97	6	dl	dl	PROPN
ajlm-622	97	7	,	,	PUNCT
ajlm-622	97	8	chaisson	chaisson	PROPN
ajlm-622	97	9	re	re	PROPN
ajlm-622	97	10	,	,	PUNCT
ajlm-622	97	11	moore	moore	PROPN
ajlm-622	97	12	rd	rd	PROPN
ajlm-622	97	13	.	.	PUNCT
ajlm-622	98	1	hepatotoxicity	hepatotoxicity	PROPN
ajlm-622	98	2	associated	associate	VERB
ajlm-622	98	3	with	with	ADP
ajlm-622	98	4	antiretroviral	antiretroviral	ADJ
ajlm-622	98	5	therapy	therapy	NOUN
ajlm-622	98	6	in	in	ADP
ajlm-622	98	7	adults	adult	NOUN
ajlm-622	98	8	infected	infect	VERB
ajlm-622	98	9	with	with	ADP
ajlm-622	98	10	human	human	ADJ
ajlm-622	98	11	immunodeficiency	immunodeficiency	NOUN
ajlm-622	98	12	virus	virus	NOUN
ajlm-622	98	13	and	and	CCONJ
ajlm-622	98	14	the	the	DET
ajlm-622	98	15	role	role	NOUN
ajlm-622	98	16	of	of	ADP
ajlm-622	98	17	hepatitis	hepatitis	PROPN
ajlm-622	98	18	c	c	PROPN
ajlm-622	98	19	or	or	CCONJ
ajlm-622	98	20	b	b	PROPN
ajlm-622	98	21	virus	virus	NOUN
ajlm-622	98	22	infection	infection	NOUN
ajlm-622	98	23	.	.	PUNCT
ajlm-622	99	1	j	j	PROPN
ajlm-622	99	2	am	be	AUX
ajlm-622	99	3	med	med	ADJ
ajlm-622	99	4	assoc	assoc	NOUN
ajlm-622	99	5	.	.	PUNCT
ajlm-622	100	1	2000;283(1):74–80	2000;283(1):74–80	NUM
ajlm-622	100	2	.	.	PUNCT
ajlm-622	101	1	https://doi.org/10.1001/jama.283.1.74	https://doi.org/10.1001/jama.283.1.74	ADJ
ajlm-622	101	2	hoffmann	hoffmann	PROPN
ajlm-622	101	3	cj	cj	PROPN
ajlm-622	101	4	,	,	PUNCT
ajlm-622	101	5	charalambous	charalambous	PROPN
ajlm-622	101	6	s	s	PROPN
ajlm-622	101	7	,	,	PUNCT
ajlm-622	101	8	thio	thio	NOUN
ajlm-622	101	9	cl	cl	NOUN
ajlm-622	101	10	,	,	PUNCT
ajlm-622	101	11	et	et	PROPN
ajlm-622	101	12	al	al	PROPN
ajlm-622	101	13	.	.	PUNCT
ajlm-622	101	14	hepatotoxicity	hepatotoxicity	NOUN
ajlm-622	101	15	in	in	ADP
ajlm-622	101	16	an	an	DET
ajlm-622	101	17	african	african	ADJ
ajlm-622	101	18	antiretroviral	antiretroviral	ADJ
ajlm-622	101	19	therapy	therapy	NOUN
ajlm-622	101	20	cohort	cohort	NOUN
ajlm-622	101	21	:	:	PUNCT
ajlm-622	101	22	the	the	DET
ajlm-622	101	23	effect	effect	NOUN
ajlm-622	101	24	of	of	ADP
ajlm-622	101	25	tuberculosis	tuberculosis	NOUN
ajlm-622	101	26	and	and	CCONJ
ajlm-622	101	27	hepatitis	hepatitis	PROPN
ajlm-622	101	28	b.	b.	PROPN
ajlm-622	101	29	aids	aids	PROPN
ajlm-622	101	30	.	.	PUNCT
ajlm-622	102	1	2007;21(10):1301–1308	2007;21(10):1301–1308	X
ajlm-622	102	2	.	.	PUNCT
ajlm-622	103	1	https://doi.org/10.1097/qad.0b013e32814e6b08	https://doi.org/10.1097/qad.0b013e32814e6b08	PROPN
ajlm-622	103	2	singh	singh	PROPN
ajlm-622	103	3	as	as	ADP
ajlm-622	103	4	,	,	PUNCT
ajlm-622	103	5	masuku	masuku	PROPN
ajlm-622	103	6	mb	mb	NOUN
ajlm-622	103	7	.	.	NOUN
ajlm-622	103	8	sampling	sample	VERB
ajlm-622	103	9	techniques	technique	NOUN
ajlm-622	103	10	and	and	CCONJ
ajlm-622	103	11	determination	determination	NOUN
ajlm-622	103	12	of	of	ADP
ajlm-622	103	13	sample	sample	NOUN
ajlm-622	103	14	size	size	NOUN
ajlm-622	103	15	in	in	ADP
ajlm-622	103	16	applied	apply	VERB
ajlm-622	103	17	statistics	statistic	NOUN
ajlm-622	103	18	research	research	NOUN
ajlm-622	103	19	:	:	PUNCT
ajlm-622	103	20	an	an	DET
ajlm-622	103	21	overview	overview	NOUN
ajlm-622	103	22	.	.	PUNCT
ajlm-622	104	1	international	international	ADJ
ajlm-622	104	2	journal	journal	PROPN
ajlm-622	104	3	of	of	ADP
ajlm-622	104	4	economics	economic	NOUN
ajlm-622	104	5	,	,	PUNCT
ajlm-622	104	6	commerce	commerce	NOUN
ajlm-622	104	7	and	and	CCONJ
ajlm-622	104	8	management	management	NOUN
ajlm-622	104	9	.	.	PUNCT
ajlm-622	104	10	2014;2(11	2014;2(11	NUM
ajlm-622	104	11	)	)	PUNCT
ajlm-622	104	12	.	.	PUNCT
ajlm-622	105	1	solomon	solomon	PROPN
ajlm-622	105	2	o	o	PROPN
ajlm-622	105	3	,	,	PUNCT
ajlm-622	105	4	mahafroz	mahafroz	PROPN
ajlm-622	105	5	k	k	NOUN
ajlm-622	105	6	,	,	PUNCT
ajlm-622	105	7	mashor	mashor	NOUN
ajlm-622	105	8	m	m	PROPN
ajlm-622	105	9	,	,	PUNCT
ajlm-622	105	10	arome	arome	ADP
ajlm-622	105	11	f	f	PROPN
ajlm-622	105	12	,	,	PUNCT
ajlm-622	105	13	neha	neha	NOUN
ajlm-622	105	14	d.	d.	PROPN
ajlm-622	105	15	prevalence	prevalence	NOUN
ajlm-622	105	16	of	of	ADP
ajlm-622	105	17	hbv	hbv	NOUN
ajlm-622	105	18	among	among	ADP
ajlm-622	105	19	students	student	NOUN
ajlm-622	105	20	at	at	ADP
ajlm-622	105	21	staff	staff	NOUN
ajlm-622	105	22	at	at	ADP
ajlm-622	105	23	the	the	DET
ajlm-622	105	24	university	university	PROPN
ajlm-622	105	25	of	of	ADP
ajlm-622	105	26	jos	jos	PROPN
ajlm-622	105	27	,	,	PUNCT
ajlm-622	105	28	nigeria	nigeria	PRON
ajlm-622	105	29	:	:	PUNCT
ajlm-622	105	30	results	result	VERB
ajlm-622	105	31	from	from	ADP
ajlm-622	105	32	a	a	DET
ajlm-622	105	33	medical	medical	ADJ
ajlm-622	105	34	outreach	outreach	NOUN
ajlm-622	105	35	screening	screen	VERB
ajlm-622	105	36	programme	programme	NOUN
ajlm-622	105	37	.	.	PUNCT
ajlm-622	106	1	int	int	PROPN
ajlm-622	107	1	j	j	PROPN
ajlm-622	107	2	sci	sci	PROPN
ajlm-622	107	3	res	res	PROPN
ajlm-622	107	4	.	.	PUNCT
ajlm-622	107	5	2014	2014	NUM
ajlm-622	107	6	;	;	PUNCT
ajlm-622	107	7	4(11).:1–5	4(11).:1–5	PROPN
ajlm-622	107	8	hamza	hamza	PROPN
ajlm-622	107	9	m	m	PROPN
ajlm-622	107	10	,	,	PUNCT
ajlm-622	107	11	samaila	samaila	PROPN
ajlm-622	107	12	aa	aa	PROPN
ajlm-622	107	13	,	,	PUNCT
ajlm-622	107	14	yakasai	yakasai	PROPN
ajlm-622	107	15	ma	ma	PROPN
ajlm-622	107	16	,	,	PUNCT
ajlm-622	107	17	et	et	PROPN
ajlm-622	107	18	al	al	PROPN
ajlm-622	107	19	.	.	PUNCT
ajlm-622	108	1	prevalence	prevalence	NOUN
ajlm-622	108	2	of	of	ADP
ajlm-622	108	3	hepatitis	hepatitis	PROPN
ajlm-622	108	4	b	b	PROPN
ajlm-622	108	5	and	and	CCONJ
ajlm-622	108	6	c	c	PROPN
ajlm-622	108	7	virus	virus	NOUN
ajlm-622	108	8	infection	infection	NOUN
ajlm-622	108	9	among	among	ADP
ajlm-622	108	10	hiv	hiv	PROPN
ajlm-622	108	11	-	-	PUNCT
ajlm-622	108	12	infected	infect	VERB
ajlm-622	108	13	patients	patient	NOUN
ajlm-622	108	14	in	in	ADP
ajlm-622	108	15	a	a	DET
ajlm-622	108	16	tertiary	tertiary	ADJ
ajlm-622	108	17	hospital	hospital	NOUN
ajlm-622	108	18	in	in	ADP
ajlm-622	108	19	north	north	NOUN
ajlm-622	108	20	-	-	PUNCT
ajlm-622	108	21	western	western	NOUN
ajlm-622	108	22	nigeria	nigeria	PROPN
ajlm-622	108	23	.	.	PUNCT
ajlm-622	109	1	niger	niger	PROPN
ajlm-622	109	2	j	j	PROPN
ajlm-622	109	3	bas	bas	PROPN
ajlm-622	109	4	clin	clin	PROPN
ajlm-622	109	5	sci	sci	PROPN
ajlm-622	109	6	.	.	PROPN
ajlm-622	110	1	2013;10:7–81	2013;10:7–81	NUM
ajlm-622	110	2	.	.	PUNCT
ajlm-622	111	1	https://doi.org/10.4103/0331-8540.122765	https://doi.org/10.4103/0331-8540.122765	PROPN
ajlm-622	111	2	tremeau	tremeau	NOUN
ajlm-622	111	3	-	-	PUNCT
ajlm-622	111	4	bravard	bravard	NOUN
ajlm-622	111	5	a	a	PRON
ajlm-622	111	6	,	,	PUNCT
ajlm-622	111	7	ogbukagu	ogbukagu	PROPN
ajlm-622	111	8	ic	ic	PROPN
ajlm-622	111	9	,	,	PUNCT
ajlm-622	111	10	ticao	ticao	PROPN
ajlm-622	111	11	cj	cj	PROPN
ajlm-622	111	12	,	,	PUNCT
ajlm-622	111	13	abubakar	abubakar	PROPN
ajlm-622	111	14	jj	jj	PROPN
ajlm-622	111	15	.	.	PROPN
ajlm-622	111	16	seroprevalence	seroprevalence	NOUN
ajlm-622	111	17	of	of	ADP
ajlm-622	111	18	hepatitis	hepatitis	PROPN
ajlm-622	111	19	b	b	PROPN
ajlm-622	111	20	and	and	CCONJ
ajlm-622	111	21	c	c	PROPN
ajlm-622	111	22	among	among	ADP
ajlm-622	111	23	hiv	hiv	PROPN
ajlm-622	111	24	-	-	PUNCT
ajlm-622	111	25	positive	positive	ADJ
ajlm-622	111	26	population	population	NOUN
ajlm-622	111	27	in	in	ADP
ajlm-622	111	28	abuja	abuja	PROPN
ajlm-622	111	29	,	,	PUNCT
ajlm-622	111	30	nigeria	nigeria	PROPN
ajlm-622	111	31	.	.	PUNCT
ajlm-622	112	1	afr	afr	PROPN
ajlm-622	112	2	j	j	PROPN
ajlm-622	112	3	health	health	PROPN
ajlm-622	112	4	sci	sci	PROPN
ajlm-622	112	5	.	.	PUNCT
ajlm-622	113	1	2012;12(3):312–317	2012;12(3):312–317	NUM
ajlm-622	113	2	.	.	X
ajlm-622	113	3	adewole	adewole	NOUN
ajlm-622	113	4	oo	oo	ADV
ajlm-622	113	5	,	,	PUNCT
ajlm-622	113	6	anteyi	anteyi	VERB
ajlm-622	113	7	e	e	NOUN
ajlm-622	113	8	,	,	PUNCT
ajlm-622	113	9	ajuwon	ajuwon	VERB
ajlm-622	113	10	z	z	PROPN
ajlm-622	113	11	,	,	PUNCT
ajlm-622	113	12	et	et	PROPN
ajlm-622	113	13	al	al	PROPN
ajlm-622	113	14	.	.	PUNCT
ajlm-622	114	1	hepatitis	hepatitis	PROPN
ajlm-622	114	2	b	b	PROPN
ajlm-622	114	3	and	and	CCONJ
ajlm-622	114	4	c	c	PROPN
ajlm-622	114	5	virus	virus	NOUN
ajlm-622	114	6	co	co	NOUN
ajlm-622	114	7	-	-	NOUN
ajlm-622	114	8	infection	infection	NOUN
ajlm-622	114	9	in	in	ADP
ajlm-622	114	10	nigerian	nigerian	ADJ
ajlm-622	114	11	patients	patient	NOUN
ajlm-622	114	12	with	with	ADP
ajlm-622	114	13	hiv	hiv	PROPN
ajlm-622	114	14	infection	infection	NOUN
ajlm-622	114	15	.	.	PUNCT
ajlm-622	115	1	j	j	PROPN
ajlm-622	115	2	infect	infect	PROPN
ajlm-622	115	3	dev	dev	PROPN
ajlm-622	115	4	ctries	ctrie	NOUN
ajlm-622	115	5	.	.	PUNCT
ajlm-622	116	1	2009;3(5):369–375	2009;3(5):369–375	X
ajlm-622	116	2	.	.	PUNCT
ajlm-622	117	1	https://doi.org/10.3855/jidc.245	https://doi.org/10.3855/jidc.245	PROPN
ajlm-622	117	2	opaleye	opaleye	NOUN
ajlm-622	117	3	oo	oo	ADV
ajlm-622	117	4	,	,	PUNCT
ajlm-622	117	5	oluremi	oluremi	ADV
ajlm-622	117	6	as	as	SCONJ
ajlm-622	117	7	,	,	PUNCT
ajlm-622	117	8	ogbolu	ogbolu	PROPN
ajlm-622	117	9	do	do	VERB
ajlm-622	117	10	,	,	PUNCT
ajlm-622	117	11	babalola	babalola	PROPN
ajlm-622	117	12	ba	ba	PROPN
ajlm-622	117	13	,	,	PUNCT
ajlm-622	117	14	shittu	shittu	PROPN
ajlm-622	117	15	b	b	NOUN
ajlm-622	117	16	,	,	PUNCT
ajlm-622	117	17	adesiyan	adesiyan	ADJ
ajlm-622	117	18	aa	aa	NOUN
ajlm-622	117	19	.	.	PUNCT
ajlm-622	118	1	prevalence	prevalence	NOUN
ajlm-622	118	2	of	of	ADP
ajlm-622	118	3	hepatitis	hepatitis	NOUN
ajlm-622	118	4	-	-	PUNCT
ajlm-622	118	5	b	b	PROPN
ajlm-622	118	6	virus	virus	NOUN
ajlm-622	118	7	infection	infection	NOUN
ajlm-622	118	8	among	among	ADP
ajlm-622	118	9	hiv	hiv	PROPN
ajlm-622	118	10	patients	patient	NOUN
ajlm-622	118	11	in	in	ADP
ajlm-622	118	12	ikole	ikole	NOUN
ajlm-622	118	13	ekiti	ekiti	NOUN
ajlm-622	118	14	,	,	PUNCT
ajlm-622	118	15	south	south	ADJ
ajlm-622	118	16	-	-	PUNCT
ajlm-622	118	17	western	western	PROPN
ajlm-622	118	18	nigeria	nigeria	PROPN
ajlm-622	118	19	.	.	PUNCT
ajlm-622	119	1	asia	asia	PROPN
ajlm-622	119	2	pac	pac	PROPN
ajlm-622	119	3	j	j	PROPN
ajlm-622	119	4	health	health	PROPN
ajlm-622	119	5	sci	sci	PROPN
ajlm-622	119	6	.	.	PUNCT
ajlm-622	120	1	2014;1(4):507–511	2014;1(4):507–511	NUM
ajlm-622	120	2	.	.	PUNCT
ajlm-622	121	1	https://doi.org/10.21276/apjhs.2014.1.4.35	https://doi.org/10.21276/apjhs.2014.1.4.35	PROPN
ajlm-622	121	2	akhtar	akhtar	PROPN
ajlm-622	121	3	a	a	PROPN
ajlm-622	121	4	,	,	PUNCT
ajlm-622	121	5	khan	khan	PROPN
ajlm-622	121	6	ah	ah	INTJ
ajlm-622	121	7	,	,	PUNCT
ajlm-622	121	8	sulaiman	sulaiman	PROPN
ajlm-622	121	9	sa	sa	PROPN
ajlm-622	121	10	,	,	PUNCT
ajlm-622	121	11	soo	soo	PROPN
ajlm-622	121	12	ct	ct	PROPN
ajlm-622	121	13	,	,	PUNCT
ajlm-622	121	14	khan	khan	PROPN
ajlm-622	121	15	k.	k.	PROPN
ajlm-622	121	16	hbv	hbv	PROPN
ajlm-622	121	17	and	and	CCONJ
ajlm-622	121	18	hiv	hiv	PROPN
ajlm-622	121	19	co	co	NOUN
ajlm-622	121	20	-	-	NOUN
ajlm-622	121	21	infection	infection	NOUN
ajlm-622	121	22	:	:	PUNCT
ajlm-622	121	23	prevalence	prevalence	NOUN
ajlm-622	121	24	and	and	CCONJ
ajlm-622	121	25	clinical	clinical	ADJ
ajlm-622	121	26	outcomes	outcome	NOUN
ajlm-622	121	27	in	in	ADP
ajlm-622	121	28	tertiary	tertiary	ADJ
ajlm-622	121	29	care	care	NOUN
ajlm-622	121	30	hospital	hospital	PROPN
ajlm-622	121	31	malaysia	malaysia	PROPN
ajlm-622	121	32	.	.	PUNCT
ajlm-622	122	1	j	j	PROPN
ajlm-622	122	2	med	med	PROPN
ajlm-622	122	3	virol	virol	NOUN
ajlm-622	122	4	.	.	PUNCT
ajlm-622	123	1	2016;88:455–460	2016;88:455–460	X
ajlm-622	123	2	.	.	PUNCT
ajlm-622	124	1	https://doi.org/10.1002/jmv.24347	https://doi.org/10.1002/jmv.24347	PROPN
ajlm-622	124	2	mustapha	mustapha	PROPN
ajlm-622	124	3	sk	sk	PROPN
ajlm-622	124	4	,	,	PUNCT
ajlm-622	124	5	jibrin	jibrin	NOUN
ajlm-622	124	6	yb	yb	PROPN
ajlm-622	124	7	.	.	PUNCT
ajlm-622	125	1	the	the	DET
ajlm-622	125	2	prevalence	prevalence	NOUN
ajlm-622	125	3	of	of	ADP
ajlm-622	125	4	hepatitis	hepatitis	PROPN
ajlm-622	125	5	b	b	PROPN
ajlm-622	125	6	surface	surface	NOUN
ajlm-622	125	7	antigenaemia	antigenaemia	PROPN
ajlm-622	125	8	in	in	ADP
ajlm-622	125	9	patients	patient	NOUN
ajlm-622	125	10	with	with	ADP
ajlm-622	125	11	human	human	ADJ
ajlm-622	125	12	immunodeficiency	immunodeficiency	NOUN
ajlm-622	125	13	virus	virus	NOUN
ajlm-622	125	14	(	(	PUNCT
ajlm-622	125	15	hiv	hiv	NOUN
ajlm-622	125	16	)	)	PUNCT
ajlm-622	125	17	infection	infection	NOUN
ajlm-622	125	18	in	in	ADP
ajlm-622	125	19	gombe	gombe	ADJ
ajlm-622	125	20	,	,	PUNCT
ajlm-622	125	21	nigeria	nigeria	PROPN
ajlm-622	125	22	.	.	PUNCT
ajlm-622	126	1	ann	ann	PROPN
ajlm-622	126	2	afr	afr	PROPN
ajlm-622	126	3	med	med	PROPN
ajlm-622	126	4	.	.	PUNCT
ajlm-622	127	1	2004;3(1):10–12	2004;3(1):10–12	NUM
ajlm-622	127	2	.	.	PUNCT
ajlm-622	128	1	ott	ott	PROPN
ajlm-622	128	2	jj	jj	PROPN
ajlm-622	128	3	,	,	PUNCT
ajlm-622	128	4	stevens	stevens	PROPN
ajlm-622	128	5	ga	ga	PROPN
ajlm-622	128	6	,	,	PUNCT
ajlm-622	128	7	groeger	groeger	PROPN
ajlm-622	128	8	j	j	PROPN
ajlm-622	128	9	,	,	PUNCT
ajlm-622	128	10	wiersma	wiersma	PROPN
ajlm-622	128	11	s.	s.	PROPN
ajlm-622	128	12	global	global	ADJ
ajlm-622	128	13	epidemiology	epidemiology	PROPN
ajlm-622	128	14	of	of	ADP
ajlm-622	128	15	hepatitis	hepatitis	PROPN
ajlm-622	128	16	b	b	PROPN
ajlm-622	128	17	virus	virus	NOUN
ajlm-622	128	18	infection	infection	NOUN
ajlm-622	128	19	:	:	PUNCT
ajlm-622	128	20	new	new	ADJ
ajlm-622	128	21	estimates	estimate	NOUN
ajlm-622	128	22	of	of	ADP
ajlm-622	128	23	age	age	NOUN
ajlm-622	128	24	-	-	PUNCT
ajlm-622	128	25	specific	specific	ADJ
ajlm-622	128	26	hbsag	hbsag	ADJ
ajlm-622	128	27	seroprevalence	seroprevalence	NOUN
ajlm-622	128	28	and	and	CCONJ
ajlm-622	128	29	endemicity	endemicity	NOUN
ajlm-622	128	30	.	.	PUNCT
ajlm-622	129	1	vaccine	vaccine	NOUN
ajlm-622	129	2	2012;30(12):2212–2219	2012;30(12):2212–2219	NUM
ajlm-622	129	3	.	.	PUNCT
ajlm-622	130	1	https://doi.org/10.1016/j.vaccine.2011.12.116	https://doi.org/10.1016/j.vaccine.2011.12.116	PROPN
ajlm-622	130	2	ikobah	ikobah	PROPN
ajlm-622	130	3	j	j	PROPN
ajlm-622	130	4	,	,	PUNCT
ajlm-622	130	5	okpara	okpara	PROPN
ajlm-622	130	6	h	h	NOUN
ajlm-622	130	7	,	,	PUNCT
ajlm-622	130	8	elemi	elemi	PROPN
ajlm-622	130	9	i	i	PROPN
ajlm-622	130	10	,	,	PUNCT
ajlm-622	130	11	ogarepe	ogarepe	PROPN
ajlm-622	130	12	y	y	PROPN
ajlm-622	130	13	,	,	PUNCT
ajlm-622	130	14	udoh	udoh	PROPN
ajlm-622	130	15	e	e	PROPN
ajlm-622	130	16	,	,	PUNCT
ajlm-622	130	17	ekanem	ekanem	PROPN
ajlm-622	130	18	e.	e.	PROPN
ajlm-622	131	1	the	the	DET
ajlm-622	131	2	prevalence	prevalence	NOUN
ajlm-622	131	3	of	of	ADP
ajlm-622	131	4	hepatitis	hepatitis	PROPN
ajlm-622	131	5	b	b	PROPN
ajlm-622	131	6	virus	virus	NOUN
ajlm-622	131	7	infection	infection	NOUN
ajlm-622	131	8	in	in	ADP
ajlm-622	131	9	nigerian	nigerian	ADJ
ajlm-622	131	10	children	child	NOUN
ajlm-622	131	11	prior	prior	ADV
ajlm-622	131	12	to	to	ADP
ajlm-622	131	13	vaccine	vaccine	NOUN
ajlm-622	131	14	introduction	introduction	NOUN
ajlm-622	131	15	into	into	ADP
ajlm-622	131	16	the	the	DET
ajlm-622	131	17	national	national	ADJ
ajlm-622	131	18	programme	programme	NOUN
ajlm-622	131	19	on	on	ADP
ajlm-622	131	20	immunization	immunization	NOUN
ajlm-622	131	21	schedule	schedule	NOUN
ajlm-622	131	22	.	.	PUNCT
ajlm-622	132	1	pan	pan	PROPN
ajlm-622	132	2	afr	afr	PROPN
ajlm-622	132	3	med	med	PROPN
ajlm-622	132	4	j.	j.	PROPN
ajlm-622	132	5	2016;23:128	2016;23:128	PROPN
ajlm-622	132	6	,	,	PUNCT
ajlm-622	132	7	1–9	1–9	PROPN
ajlm-622	132	8	.	.	PUNCT
ajlm-622	132	9	https://doi.org/10.11604/pamj.2016.23.128.8756	https://doi.org/10.11604/pamj.2016.23.128.8756	PROPN
ajlm-622	132	10	otegbayo	otegbayo	PROPN
ajlm-622	132	11	ja	ja	PROPN
ajlm-622	132	12	,	,	PUNCT
ajlm-622	132	13	taiwo	taiwo	PROPN
ajlm-622	132	14	bo	bo	PROPN
ajlm-622	132	15	,	,	PUNCT
ajlm-622	132	16	akingbola	akingbola	PROPN
ajlm-622	132	17	ts	ts	PROPN
ajlm-622	132	18	,	,	PUNCT
ajlm-622	132	19	et	et	PROPN
ajlm-622	132	20	al	al	PROPN
ajlm-622	132	21	.	.	PUNCT
ajlm-622	133	1	prevalence	prevalence	NOUN
ajlm-622	133	2	of	of	ADP
ajlm-622	133	3	hepatitis	hepatitis	PROPN
ajlm-622	133	4	b	b	PROPN
ajlm-622	133	5	and	and	CCONJ
ajlm-622	133	6	c	c	PROPN
ajlm-622	133	7	positivity	positivity	NOUN
ajlm-622	133	8	in	in	ADP
ajlm-622	133	9	a	a	DET
ajlm-622	133	10	nigerian	nigerian	ADJ
ajlm-622	133	11	cohort	cohort	NOUN
ajlm-622	133	12	of	of	ADP
ajlm-622	133	13	hiv	hiv	PROPN
ajlm-622	133	14	-	-	PUNCT
ajlm-622	133	15	infected	infect	VERB
ajlm-622	133	16	patients	patient	NOUN
ajlm-622	133	17	.	.	PUNCT
ajlm-622	134	1	ann	ann	PROPN
ajlm-622	134	2	hepatol	hepatol	ADJ
ajlm-622	134	3	.	.	PUNCT
ajlm-622	135	1	2008;7(2):152–156	2008;7(2):152–156	X
ajlm-622	135	2	.	.	X
ajlm-622	135	3	vigano	vigano	PROPN
ajlm-622	135	4	m	m	PROPN
ajlm-622	135	5	,	,	PUNCT
ajlm-622	135	6	lampertico	lampertico	NOUN
ajlm-622	135	7	p.	p.	NOUN
ajlm-622	135	8	clinical	clinical	ADJ
ajlm-622	135	9	implications	implication	NOUN
ajlm-622	135	10	of	of	ADP
ajlm-622	135	11	hbsag	hbsag	ADJ
ajlm-622	135	12	quantification	quantification	NOUN
ajlm-622	135	13	in	in	ADP
ajlm-622	135	14	patients	patient	NOUN
ajlm-622	135	15	with	with	ADP
ajlm-622	135	16	chronic	chronic	ADJ
ajlm-622	135	17	hepatitis	hepatitis	PROPN
ajlm-622	135	18	b.	b.	PROPN
ajlm-622	135	19	saud	saud	PROPN
ajlm-622	135	20	j	j	PROPN
ajlm-622	135	21	gastroenterol	gastroenterol	PROPN
ajlm-622	135	22	.	.	PUNCT
ajlm-622	136	1	2012;18(2):81–86	2012;18(2):81–86	NUM
ajlm-622	136	2	.	.	PUNCT
ajlm-622	137	1	https://doi.org/10.4103/1319-3767.93805	https://doi.org/10.4103/1319-3767.93805	PROPN
ajlm-622	137	2	chan	chan	PROPN
ajlm-622	137	3	hl	hl	PROPN
ajlm-622	137	4	,	,	PUNCT
ajlm-622	137	5	wong	wong	PROPN
ajlm-622	137	6	vw	vw	PROPN
ajlm-622	137	7	,	,	PUNCT
ajlm-622	137	8	tse	tse	PROPN
ajlm-622	137	9	am	am	PROPN
ajlm-622	137	10	,	,	PUNCT
ajlm-622	137	11	et	et	PROPN
ajlm-622	137	12	al	al	PROPN
ajlm-622	137	13	.	.	PROPN
ajlm-622	137	14	serum	serum	PROPN
ajlm-622	137	15	hepatitis	hepatitis	PROPN
ajlm-622	137	16	b	b	PROPN
ajlm-622	137	17	surface	surface	NOUN
ajlm-622	137	18	antigen	antigen	ADJ
ajlm-622	137	19	quantitation	quantitation	NOUN
ajlm-622	137	20	can	can	AUX
ajlm-622	137	21	reflect	reflect	VERB
ajlm-622	137	22	hepatitis	hepatitis	PROPN
ajlm-622	137	23	b	b	PROPN
ajlm-622	137	24	virus	virus	NOUN
ajlm-622	137	25	in	in	ADP
ajlm-622	137	26	the	the	DET
ajlm-622	137	27	liver	liver	NOUN
ajlm-622	137	28	and	and	CCONJ
ajlm-622	137	29	predict	predict	VERB
ajlm-622	137	30	treatment	treatment	NOUN
ajlm-622	137	31	response	response	NOUN
ajlm-622	137	32	.	.	PUNCT
ajlm-622	138	1	clin	clin	PROPN
ajlm-622	138	2	enterol	enterol	PROPN
ajlm-622	138	3	hepatol	hepatol	ADJ
ajlm-622	138	4	.	.	PUNCT
ajlm-622	139	1	2007;5:1462–1468	2007;5:1462–1468	NUM
ajlm-622	139	2	.	.	PUNCT
ajlm-622	140	1	https://doi.org/10.1016/j.cgh.2007.09.005	https://doi.org/10.1016/j.cgh.2007.09.005	X
ajlm-622	140	2	jaroszewicz	jaroszewicz	PROPN
ajlm-622	140	3	j	j	PROPN
ajlm-622	140	4	,	,	PUNCT
ajlm-622	140	5	serrano	serrano	PROPN
ajlm-622	140	6	bc	bc	PROPN
ajlm-622	140	7	,	,	PUNCT
ajlm-622	140	8	wursthorn	wursthorn	VERB
ajlm-622	140	9	k	k	PROPN
ajlm-622	140	10	,	,	PUNCT
ajlm-622	140	11	et	et	PROPN
ajlm-622	140	12	al	al	PROPN
ajlm-622	140	13	.	.	PUNCT
ajlm-622	141	1	hepatitis	hepatitis	PROPN
ajlm-622	141	2	b	b	PROPN
ajlm-622	141	3	surface	surface	NOUN
ajlm-622	141	4	antigen	antigen	ADJ
ajlm-622	141	5	levels	level	NOUN
ajlm-622	141	6	in	in	ADP
ajlm-622	141	7	the	the	DET
ajlm-622	141	8	natural	natural	ADJ
ajlm-622	141	9	history	history	NOUN
ajlm-622	141	10	of	of	ADP
ajlm-622	141	11	hepatitis	hepatitis	PROPN
ajlm-622	141	12	b	b	PROPN
ajlm-622	141	13	virus	virus	NOUN
ajlm-622	141	14	(	(	PUNCT
ajlm-622	141	15	hbv	hbv	NOUN
ajlm-622	141	16	)	)	PUNCT
ajlm-622	141	17	infection	infection	NOUN
ajlm-622	141	18	:	:	PUNCT
ajlm-622	141	19	a	a	DET
ajlm-622	141	20	european	european	ADJ
ajlm-622	141	21	perspective	perspective	NOUN
ajlm-622	141	22	.	.	PUNCT
ajlm-622	142	1	j	j	PROPN
ajlm-622	142	2	hepatol	hepatol	ADJ
ajlm-622	142	3	.	.	PUNCT
ajlm-622	143	1	2010;52:514–522	2010;52:514–522	X
ajlm-622	143	2	.	.	PUNCT
ajlm-622	144	1	https://doi.org/10.1016/j.jhep.2010.01.014	https://doi.org/10.1016/j.jhep.2010.01.014	X
ajlm-622	144	2	nguyen	nguyen	PROPN
ajlm-622	144	3	t	t	PROPN
ajlm-622	144	4	,	,	PUNCT
ajlm-622	144	5	thompson	thompson	PROPN
ajlm-622	144	6	ajv	ajv	PROPN
ajlm-622	144	7	,	,	PUNCT
ajlm-622	144	8	bowden	bowden	PROPN
ajlm-622	144	9	s	s	PROPN
ajlm-622	144	10	,	,	PUNCT
ajlm-622	144	11	et	et	PROPN
ajlm-622	144	12	al	al	PROPN
ajlm-622	144	13	.	.	PUNCT
ajlm-622	145	1	hepatitis	hepatitis	PROPN
ajlm-622	145	2	b	b	PROPN
ajlm-622	145	3	surface	surface	NOUN
ajlm-622	145	4	antigen	antigen	ADJ
ajlm-622	145	5	levels	level	NOUN
ajlm-622	145	6	during	during	ADP
ajlm-622	145	7	the	the	DET
ajlm-622	145	8	natural	natural	ADJ
ajlm-622	145	9	history	history	NOUN
ajlm-622	145	10	of	of	ADP
ajlm-622	145	11	chronic	chronic	ADJ
ajlm-622	145	12	hepatitis	hepatitis	NOUN
ajlm-622	145	13	:	:	PUNCT
ajlm-622	145	14	a	a	DET
ajlm-622	145	15	perspective	perspective	NOUN
ajlm-622	145	16	on	on	ADP
ajlm-622	145	17	asia	asia	PROPN
ajlm-622	145	18	.	.	PUNCT
ajlm-622	146	1	j	j	PROPN
ajlm-622	146	2	hepatol	hepatol	ADJ
ajlm-622	146	3	.	.	PUNCT
ajlm-622	147	1	2010;52:508–513	2010;52:508–513	X
ajlm-622	147	2	.	.	PUNCT
ajlm-622	148	1	https://doi.org/10.1016/j.jhep.2010.01.007	https://doi.org/10.1016/j.jhep.2010.01.007	NOUN